Pubmed-indexed Papers on Covid Vaccine Injury

Print

Link copied

Subjects on this page:

• Myocarditis and pericarditis
• Cardiomyopathy
• Thrombosis, thrombocytopenia, and hemorrhage
• Vasculitis, including henoch-schönlein purpura
• Neurology
• Hepatitis
• Other auto-immune disease or reactivation of auto-immune disease
• Anaphylaxis, allergic reactions, and asthma
• Lymphadenopathy and axillary adenopathy
• Cutaneous (skin) effects
• Eye disorders
• Rhabdomyolysis
• Kidney injury
• Myofunctional
• Infections
• Other rare disorders
• Population studies
• Cancer progression
• Death

Myocarditis and pericarditis

Inflammation of the heart muscle (myocardium) or sack around the heart (pericardium). This inflammation can reduce the heart’s ability to pump and cause rapid irregular heart rhythms (arrhythmias). Signs and symptoms include chest pain, fatigue, shortness of breath and rapid or irregular heartbeats. In a small percentage of cases, persons with myocarditis can be at risk for sudden death following strenuous activity. Some sufferers of myocarditis may require heart surgery or a heart transplant in later life.

1. Autopsy Histopathologic Cardiac Findings in Two Adolescents Following the Second COVID-19 Vaccine Dose (2022). Arch Pathol Lab Med [PubMed]
2. Acute myocarditis after SARS-CoV-2 vaccination in a 24-year-old man (2022). Rev Port Cardiol [PubMed]
3. Hypersensitivity myocarditis and COVID-19 vaccines (2022). Kardiol Pol [PubMed]
4. Biventricular systolic dysfunction in acute myocarditis after SARS-CoV-2 mRNA-1273 vaccination (2022). Eur Heart J Cardiovasc Imaging [PubMed]
5. Clinically Suspected Myocarditis Temporally Related to COVID-19 Vaccination in Adolescents and Young Adults: Suspected Myocarditis After COVID-19 Vaccination (2022). Circulation [PubMed]
6. 68Ga-DOTATOC digital-PET imaging of inflammatory cell infiltrates in myocarditis following COVID-19 vaccination (2022). Eur J Nucl Med Mol Imaging [PubMed]
7. Self-limited myocarditis presenting with chest pain and ST segment elevation in adolescents after vaccination with the BNT162b2 mRNA vaccine (2022). Cardiol Young [PubMed]
8. Acute Myocardial Infarction Within 24 Hours After COVID-19 Vaccination: Is Kounis Syndrome the Culprit? (2022). Am J Cardiol [PubMed]
9. Population-based Incidence of Myopericarditis After COVID-19 Vaccination in Danish Adolescents (2022). Pediatr Infect Dis J [PubMed]
10. Definite Acute Myocarditis After Coronavirus Disease 2019 mRNA Vaccination (2022). Circ J [PubMed]
11. mRNA Coronavirus Disease 2019 Vaccine-Associated Myopericarditis in Adolescents: A Survey Study (2022). J Pediatr [PubMed]
12. Myocarditis Following a COVID-19 Messenger RNA Vaccination: A Japanese Case Series (2022). Intern Med [PubMed]
13. Young Male With Myocarditis Following mRNA-1273 Vaccination Against Coronavirus Disease-2019 (COVID-19) (2022). Circ J [PubMed]
14. Recurrence of Myopericarditis Following mRNA COVID-19 Vaccination in a Male Adolescent (2022). CJC Open [PubMed]
15. Should T2 mapping be used in cases of recurrent myocarditis to differentiate between the acute inflammation and chronic scar? (2022). J Pediatr [PubMed]
16. Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID-19 vaccination (2022). J Cutan Pathol [PubMed]
17. Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection (2022). Nat Med [PubMed]
18. Cardiac MRI Findings of Myocarditis After COVID-19 mRNA Vaccination in Adolescents (2022). AJR Am J Roentgenol [PubMed]
19. Features of Inflammatory Heart Reactions Following mRNA COVID-19 Vaccination at a Global Level (2022). Clin Pharmacol Ther [PubMed]
20. Myocarditis and pericarditis in adolescents after first and second doses of mRNA COVID-19 vaccines (2022). Eur Heart J Qual Care Clin Outcomes [PubMed]
21. Myocarditis following COVID-19 vaccination – A case series (2021). Vaccine [PubMed]
22. Untimely Myocardial Infarction or COVID-19 Vaccine Side Effect (2021). Cureus [PubMed]
23. Fulminant myocarditis and systemic hyperinflammation temporally associated with BNT162b2 mRNA COVID-19 vaccination in two patients (2021). Int J Cardiol [PubMed]
24. Myocarditis and pericarditis in association with COVID-19 mRNA-vaccination: cases from a regional pharmacovigilance centre (2021). Glob Cardiol Sci Pract [PubMed]
25. Multimodality imaging and histopathology in a young man presenting with fulminant lymphocytic myocarditis and cardiogenic shock after mRNA-1273 vaccination (2021). BMJ Case Rep [PubMed]
26. Case Report: Acute Fulminant Myocarditis and Cardiogenic Shock After Messenger RNA Coronavirus Disease 2019 Vaccination Requiring Extracorporeal Cardiopulmonary Resuscitation (2021). Front Cardiovasc Med [PubMed]
27. STEMI Mimic: Focal Myocarditis in an Adolescent Patient After mRNA COVID-19 Vaccine (2021). J Emerg Med [PubMed]
28. Acute myocarditis after the second dose of SARS-CoV-2 vaccine: Serendipity or atypical causal relationship? (2021). Anatol J Cardiol [PubMed]
29. Acute pericarditis and cardiac tamponade after Covid-19 vaccination (2021). Singapore Med J [PubMed]
30. Important Insights into Myopericarditis after the Pfizer mRNA COVID-19 Vaccination in Adolescents (2021). J Pediatr [PubMed]
31. Myocarditis Following mRNA COVID-19 Vaccine (2021). Pediatr Emerg Care [PubMed]
32. Acute Myocarditis Following the Administration of the Second BNT162b2 COVID-19 Vaccine Dose (2021). Cureus [PubMed]
33. Biopsy-proven lymphocytic myocarditis following first mRNA COVID-19 vaccination in a 40-year-old male: case report (2021). Clin Res Cardiol [PubMed]
34. Acute Perimyocarditis Following First Dose of mRNA Vaccine Against COVID-19 (2021). Dtsch Arztebl Int [PubMed]
35. Epidemiology and Clinical Features of Myocarditis/Pericarditis before the Introduction of mRNA COVID-19 Vaccine in Korean Children: a Multicenter Study (2021). J Korean Med Sci [PubMed]
36. Acute Myocardial Injury Following COVID-19 Vaccination: A Case Report and Review of Current Evidence from Vaccine Adverse Events Reporting System Database (2021). J Prim Care Community Health [PubMed]
37. Acute myocarditis following administration of BNT162b2 vaccine (2021). IDCases [PubMed]
38. Myocarditis following COVID-19 vaccination (2021). Radiol Case Rep [PubMed]
39. Lymphohistocytic myocarditis after Ad26.COV2.S viral vector COVID-19 vaccination (2021). Int J Cardiol Heart Vasc [PubMed]
40. Myocarditis Associated with mRNA COVID-19 Vaccination (2021). Radiology [PubMed]
41. Unusual Presentation of Acute Perimyocarditis Following SARS-COV-2 mRNA-1237 Moderna Vaccination (2021). Cureus [PubMed]
42. COVID-19 vaccine-induced myocarditis: Case report with literature review (2021). Diabetes Metab Syndr [PubMed]
43. Myocarditis Associated With COVID-19 Vaccination: Echocardiography, Cardiac Tomography, and Magnetic Resonance Imaging Findings (2021). Circ Cardiovasc Imaging [PubMed]
44. A Case Report for Myopericarditis after BNT162b2 COVID-19 mRNA Vaccination in a Korean Young Male (2021). J Korean Med Sci [PubMed]
45. Temporal relation between second dose BNT162b2 mRNA Covid-19 vaccine and cardiac involvement in a patient with previous SARS-COV-2 infection (2021). Int J Cardiol Heart Vasc [PubMed]
46. Myocarditis Occurring After Immunization With mRNA-Based COVID-19 Vaccines (2021). JAMA Cardiol [PubMed]
47. Acute Myocarditis after COVID-19 vaccination: A case report (2021). Rev Med Interne [PubMed]
48. Acute myocarditis after a second dose of the mRNA COVID-19 vaccine: a report of two cases (2021). Clin Imaging [PubMed]
49. Case Report: Probable Myocarditis After Covid-19 mRNA Vaccine in a Patient With Arrhythmogenic Left Ventricular Cardiomyopathy (2021). Front Cardiovasc Med [PubMed]
50. Perimyocarditis Following COVID-19 Vaccination (2021). Clin Med Insights Cardiol [PubMed]
51. Acute Myocardial Infarction and Myocarditis following COVID-19 Vaccination (2021). QJM [PubMed]
52. In brief: Myocarditis with the Pfizer/BioNTech and Moderna COVID-19 vaccines (2021). Med Lett Drugs Ther [PubMed]
53. A Series of Patients With Myocarditis Following SARS-CoV-2 Vaccination With mRNA-1279 and BNT162b2 (2021). JACC Cardiovasc Imaging [PubMed]
54. Intravenous injection of COVID-19 mRNA vaccine can induce acute myopericarditis in mouse model (2021). Clin Infect Dis [PubMed]
55. Myocarditis following COVID-19 vaccination (2021). Int J Cardiol Heart Vasc [PubMed]
56. COVID-19 Vaccine and Myocarditis (2021). Am J Cardiol [PubMed]
57. Acute myocarditis after coronavirus disease 2019 vaccination (2021). Anatol J Cardiol [PubMed]
58. Acute myocarditis after administration of the BNT162b2 vaccine against COVID-19 (2021). Rev Esp Cardiol (Engl Ed) [PubMed]
59. COVID 19 Vaccine for Adolescents. Concern about Myocarditis and Pericarditis (2021). Pediatr Rep [PubMed]
60. A Late Presentation of COVID-19 Vaccine-Induced Myocarditis (2021). Cureus [PubMed]
61. Myocarditis after COVID-19 mRNA vaccines (2021). QJM [PubMed]
62. Myocarditis following COVID-19 vaccination: magnetic resonance imaging study (2021). Eur Heart J Cardiovasc Imaging [PubMed]
63. Myopericarditis after messenger RNA Coronavirus Disease 2019 Vaccination in Adolescents 12 to 18 Years of Age (2021). J Pediatr [PubMed]
64. A review of COVID-19 vaccination and the reported cardiac manifestations (2021). Singapore Med J [PubMed]
65. Myocarditis after BNT162b2 vaccination in a healthy male (2021). Am J Emerg Med [PubMed]
66. COVID-19 mRNA Vaccine and Myocarditis (2021). Eur J Case Rep Intern Med [PubMed]
67. Acute Myocarditis Following mRNA-1273 SARS-CoV-2 Vaccination (2021). CJC Open [PubMed]
68. Myopericarditis in a previously healthy adolescent male following COVID-19 vaccination: A case report (2021). Acad Emerg Med [PubMed]
69. Myocarditis after vaccination against covid-19 (2021). BMJ [PubMed]
70. Shedding the Light on Post-Vaccine Myocarditis and Pericarditis in COVID-19 and Non-COVID-19 Vaccine Recipients (2021). Vaccines (Basel) [PubMed]
71. mRNA COVID vaccine and myocarditis in adolescents (2021). Hong Kong Med J [PubMed]
72. Pericarditis after administration of the BNT162b2 mRNA COVID-19 vaccine (2021). Rev Esp Cardiol (Engl Ed) [PubMed]
73. Epidemiology of Acute Myocarditis/Pericarditis in Hong Kong Adolescents Following Comirnaty Vaccination (2021). Clin Infect Dis [PubMed]
74. Perimyocarditis following first dose of the mRNA-1273 SARS-CoV-2 (Moderna) vaccine in a healthy young male: a case report (2021). BMC Cardiovasc Disord [PubMed]
75. Myocarditis After SARS-CoV-2 Vaccination: A Vaccine-Induced Reaction? (2021). Can J Cardiol [PubMed]
76. Postmortem investigation of fatalities following vaccination with COVID-19 vaccines (2021). Int J Legal Med [PubMed]
77. Acute Myocarditis Associated with COVID-19 Vaccination: A Case Report (2021). J Cardiol Cases [PubMed]
78. Acute Myocarditis Following COVID-19 mRNA Vaccination in Adults Aged 18 Years or Older (2021). JAMA Intern Med [PubMed]
79. Severe COVID-19 vaccine associated myocarditis: Zebra or unicorn? (2021). Int J Cardiol [PubMed]
80. Association of Myocarditis With BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of Children (2021). JAMA Cardiol [PubMed]
81. [Pericarditis after administration of the BNT162b2 mRNA COVID-19 vaccine] (2021). Rev Esp Cardiol [PubMed]
82. Myocarditis Following COVID-19 Vaccination (2021). Radiology [PubMed]
83. Myocarditis Temporally Associated With COVID-19 Vaccination (2021). Circulation [PubMed]
84. Myocarditis should be considered in those with a troponin rise and unobstructed coronary arteries following Pfizer-BioNTech COVID-19 vaccination (2021). QJM [PubMed]
85. Myocarditis and Other Cardiovascular Complications of the mRNA-Based COVID-19 Vaccines (2021). Cureus [PubMed]
86. Cardiac complications following mRNA COVID-19 vaccines: A systematic review of case reports and case series (2021). Rev Med Virol [PubMed]
87. Chest Pain with New Abnormal Electrocardiogram Development after Injection of COVID-19 Vaccine Manufactured by Moderna (2021). Intern Med [PubMed]
88. Myocarditis-induced Sudden Death after BNT162b2 mRNA COVID-19 Vaccination in Korea: Case Report Focusing on Histopathological Findings (2021). J Korean Med Sci [PubMed]
89. Myocarditis and Pericarditis After COVID-19 mRNA Vaccination: Practical Considerations for Care Providers (2021). Can J Cardiol [PubMed]
90. Acute myocarditis following Comirnaty vaccination in a healthy man with previous SARS-CoV-2 infection (2021). Radiol Case Rep [PubMed]
91. Myocarditis With COVID-19 mRNA Vaccines (2021). Circulation [PubMed]
92. Myocarditis following mRNA vaccination against SARS-CoV-2, a case series (2021). Am Heart J Plus [PubMed]
93. Myopericarditis After the Pfizer Messenger Ribonucleic Acid Coronavirus Disease Vaccine in Adolescents (2021). J Pediatr [PubMed]
94. Myocarditis in the Setting of Recent COVID-19 Vaccination (2021). Case Rep Cardiol [PubMed]
95. Acute myocarditis associated with anti-COVID-19 vaccination (2021). Clin Exp Vaccine Res [PubMed]
96. A case report: symptomatic pericarditis post-COVID-19 vaccination (2021). Eur Heart J Case Rep [PubMed]
97. Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices – United States, June 2021 (2021). MMWR Morb Mortal Wkly Rep [PubMed]
98. Possible Association Between COVID-19 Vaccine and Myocarditis: Clinical and CMR Findings (2021). JACC Cardiovasc Imaging [PubMed]
99. Recurrence of Acute Myocarditis Temporally Associated with Receipt of the mRNA Coronavirus Disease 2019 (COVID-19) Vaccine in a Male Adolescent (2021). J Pediatr [PubMed]
100. Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel (2021). N Engl J Med [PubMed]
101. Cardiac Imaging of Acute Myocarditis Following COVID-19 mRNA Vaccination (2021). J Korean Med Sci [PubMed]
102. Perimyocarditis in Adolescents After Pfizer-BioNTech COVID-19 Vaccine (2021). J Pediatric Infect Dis Soc [PubMed]
103. Myocarditis after Covid-19 mRNA Vaccination (2021). N Engl J Med [PubMed]
104. Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase (2021). Vaccines (Basel) [PubMed]
105. Case report: acute myocarditis following the second dose of mRNA-1273 SARS-CoV-2 vaccine (2021). Eur Heart J Case Rep [PubMed]
106. The Novel Platform of mRNA COVID-19 Vaccines and Myocarditis: Clues into the Potential Underlying Mechanism (2021). Vaccine [PubMed]
107. Temporal association between the COVID-19 Ad26.COV2.S vaccine and acute myocarditis: A case report and literature review (2021). Cardiovasc Revasc Med [PubMed]
108. COVID-19 vaccines and myocarditis (2021). Arch Cardiovasc Dis [PubMed]
109. Weighing the Risks of Perimyocarditis With the Benefits of SARS-CoV-2 mRNA Vaccination in Adolescents (2021). J Pediatric Infect Dis Soc [PubMed]
110. Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination (2021). JAMA Cardiol [PubMed]
111. Cardiovascular magnetic resonance findings in young adult patients with acute myocarditis following mRNA COVID-19 vaccination: a case series (2021). J Cardiovasc Magn Reson [PubMed]
112. Myocarditis after Covid-19 Vaccination in a Large Health Care Organization (2021). N Engl J Med [PubMed]
113. Myocarditis and Pericarditis following COVID-19 Vaccination: Inequalities in Age and Vaccine Types (2021). J Pers Med [PubMed]
114. Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military (2021). JAMA Cardiol [PubMed]
115. A case series of acute pericarditis following COVID-19 vaccination in the context of recent reports from Europe and the United States (2021). Vaccine [PubMed]
116. Myocarditis, Pericarditis and Cardiomyopathy After COVID-19 Vaccination (2021). Heart Lung Circ [PubMed]
117. Eosinophilic Myocarditis Following Coronavirus Disease 2019 (COVID-19) Vaccination (2021). Circ J [PubMed]
118. Myocarditis and Pericarditis Following mRNA COVID-19 Vaccination: What Do We Know So Far? (2021). Children (Basel) [PubMed]
119. Transient Cardiac Injury in Adolescents Receiving the BNT162b2 mRNA COVID-19 Vaccine (2021). Pediatr Infect Dis J [PubMed]
120. Reply to “Letter to the editor: Myocarditis should be considered in those with a troponin rise and unobstructed coronary arteries following PfizerBioNTech COVID-19 vaccination” (2021). QJM [PubMed]
121. T2 mapping should be utilised in cases of suspected myocarditis to confirm an acute inflammatory process (2021). QJM [PubMed]
122. Myocarditis Following COVID-19 mRNA Vaccine: A Case Series and Incidence Rate Determination (2021). Clin Infect Dis [PubMed]
123. Acute Myocardial Infarction Within 24 Hours After COVID-19 Vaccination (2021). Am J Cardiol [PubMed]
124. Symptomatic Acute Myocarditis in 7 Adolescents After Pfizer-BioNTech COVID-19 Vaccination (2021). Pediatrics [PubMed]
125. Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting (2021). N Engl J Med [PubMed]
126. Myocarditis following COVID-19 mRNA vaccination (2021). Vaccine [PubMed]
127. COVID-19 Vaccination-Associated Myocarditis in Adolescents (2021). Pediatrics [PubMed]
128. In-Depth Evaluation of a Case of Presumed Myocarditis After the Second Dose of COVID-19 mRNA Vaccine (2021). Circulation [PubMed]
129. [Acute myocarditis in a young adult two days after Pfizer vaccination] (2021). G Ital Cardiol (Rome) [PubMed]
130. Occurrence of acute infarct-like myocarditis following COVID-19 vaccination: just an accidental co-incidence or rather vaccination-associated autoimmune myocarditis? (2021). Clin Res Cardiol [PubMed]
131. Insights from a murine model of COVID-19 mRNA vaccination-induced myopericarditis: Could accidental intravenous vaccine injection induce myopericarditis? (2021). Clin Infect Dis [PubMed]
132. Myocarditis and Pericarditis After Vaccination for COVID-19 (2021). JAMA [PubMed]
133. Acute Myopericarditis after COVID-19 Vaccine in Teenagers (2021). Case Rep Cardiol [PubMed]

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle that makes it harder for the heart to pump blood to the rest of the body. Cardiomyopathy can lead to heart failure.

1. Takotsubo (stress) cardiomyopathy after ChAdOx1 nCoV-19 vaccination (2021). BMJ Case Rep [PubMed]
2. Takotsubo syndrome after receiving the COVID-19 vaccine (2021). J Cardiol Cases [PubMed]
3. Takotsubo Cardiomyopathy After mRNA COVID-19 Vaccination (2021). Heart Lung Circ [PubMed]
4. Takotsubo cardiomyopathy after vaccination for coronavirus disease 2019 in a patient on maintenance hemodialysis (2021). CEN Case Rep [PubMed]
5. Myocarditis, Pericarditis and Cardiomyopathy After COVID-19 Vaccination (2021). Heart Lung Circ [PubMed]

Thrombosis, thrombocytopenia and hemorrhage

Alterations in the blood’s ability to form clots can lead to the development of clots, or paradoxically, to bleeding. This may include a lower-than-normal number of platelets in the blood, which can also result in easy bruising. People have experienced strokes and bleeding in the brain, heart attacks, blood clots to the lungs and lack of oxygen to organs, all of which can cause death. Case reports include thrombosis of the major arteries (carotid, distal aorta, iliac, splenic) and limb ischemia. Thrombosis of the venous system include cerebral venous thrombosis as well as splanchnic, renal, superior ophthalmic, portal and palmar vein thrombosis.

1. Successful Treatment of Vaccine-Induced Immune Thrombotic Thrombocytopenia in a 26-Year-Old Female Patient (2022). Acta Haematol [PubMed]
2. Three cases of acute venous thromboembolism in females after vaccination for coronavirus disease 2019 (2022). J Vasc Surg Venous Lymphat Disord [PubMed]
3. COVID-19 Vaccine-Induced Immune Thrombosis with Thrombocytopenia (VITT) and the Shades of Grey in Thrombus Formation (2022). Semin Thromb Hemost [PubMed]
4. Middle-age Asian male with cerebral venous thrombosis after COVID-19 AstraZeneca vaccination (2022). Am J Emerg Med [PubMed]
5. A case of unusual mild clinical presentation of COVID-19 vaccine-induced immune thrombotic thrombocytopenia with splanchnic vein thrombosis (2022). Ann Hepatol [PubMed]
6. Thrombosis formation after COVID-19 vaccination Immunological Aspects: Review article (2022). Saudi J Biol Sci [PubMed]
7. A case series of vaccine-induced thrombotic thrombocytopenia in a London teaching hospital (2022). Br J Clin Pharmacol [PubMed]
8. Refractory vaccine-induced immune thrombotic thrombocytopenia (VITT) managed with delayed therapeutic plasma exchange (TPE) (2022). J Clin Apher [PubMed]
9. Thrombosis and Thrombocytopenia Syndrome Causing Isolated Symptomatic Carotid Occlusion after Covid-19 Vaccine (2022). Thromb Haemost [PubMed]
10. Response to bilateral adrenal haemorrhage in the differential diagnosis of abdominal pain in vaccine-induced thrombosis with thrombocytopenia (2022). QJM [PubMed]
11. Relapse of immune thrombocytopenia after COVID-19 vaccination (2022). Eur J Haematol [PubMed]
12. Cerebral venous sinus thrombosis after mRNA-based COVID-19 vaccination (2022). Neurol Sci [PubMed]
13. Unusual Site of Deep Vein Thrombosis After mRNA Coronavirus Disease-2019 (COVID-19) Vaccination (2022). Circ J [PubMed]
14. Genital necrosis with cutaneous thrombosis after COVID-19 mRNA vaccination (2022). J Eur Acad Dermatol Venereol [PubMed]
15. Concerning the unexpected prothrombotic state following some coronavirus disease 2019 vaccines (2022). J Cardiovasc Med (Hagerstown) [PubMed]
16. Age- and Sex-Specific Incidence of Cerebral Venous Sinus Thrombosis Associated With Ad26.COV2.S COVID-19 Vaccination (2022). JAMA Intern Med [PubMed]
17. Cerebral venous sinus thrombosis associated with vaccine-induced thrombotic thrombocytopenia (2022). Neuroradiol J [PubMed]
18. Cerebral Venous Thrombosis Developing after COVID-19 Vaccination: VITT, VATT, TTS, and More (2022). Semin Thromb Hemost [PubMed]
19. Myocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older (2022). JAMA [PubMed]
20. Fatal vaccine-induced immune thrombotic thrombocytopenia (VITT) post Ad26.COV2.S: first documented case outside US (2022). Infection [PubMed]
21. CAd26.COV2‑S vaccination can reveal inherited thrombophilia: a case of massive cerebral venous sinus thrombosis in a young man with normal platelet count (2022). Pol Arch Intern Med [PubMed]
22. The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune thrombotic thrombocytopenia (2022). Trends Cardiovasc Med [PubMed]
23. Secondary thrombocytopenia after SARS-CoV-2 vaccine: Report of a case of hemorrhage and hematoma after minor oral surgery (2022). J Stomatol Oral Maxillofac Surg [PubMed]
24. Case report: cerebral sinus vein thrombosis in two patients with AstraZeneca SARS-CoV-2 vaccination (2022). J Neurol [PubMed]
25. Coronavirus (COVID-19) Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) (2022). StatPearls [PubMed]
26. Clinical and biological features of cerebral venous sinus thrombosis following ChAdOx1 nCov-19 vaccination (2022). J Neurol Neurosurg Psychiatry [PubMed]
27. Multiple Sites of Arterial Thrombosis in A 35-Year Old Patient after ChAdOx1 (AstraZeneca) Vaccination, Requiring Emergent Femoral and Carotid Surgical Thrombectomy (2022). Ann Vasc Surg [PubMed]
28. ChAdOx1 nCoV-19 vaccine-associated thrombocytopenia: three cases of immune thrombocytopenia after 107 720 doses of ChAdOx1 vaccination in Thailand (2022). Blood Coagul Fibrinolysis [PubMed]
29. Imaging and Hematologic Findings in Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 (AstraZeneca) Vaccination (2022). Radiology [PubMed]
30. Intracerebral hemorrhage associated with vaccine-induced thrombotic thrombocytopenia following ChAdOx1 nCOVID-19 vaccine in a pregnant woman (2021). Haematologica [PubMed]
31. An observational study to identify the prevalence of thrombocytopenia and anti-PF4/polyanion antibodies in Norwegian health care workers after COVID-19 vaccination (2021). J Thromb Haemost [PubMed]
32. First report of a de novo iTTP episode associated with an mRNA-based anti-COVID-19 vaccination (2021). J Thromb Haemost [PubMed]
33. Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS) (2021). Vaccine [PubMed]
34. Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia (2021). JAMA Neurol [PubMed]
35. Newly diagnosed immune thrombocytopenia in a pregnant patient after coronavirus disease 2019 vaccination (2021). J Obstet Gynaecol Res [PubMed]
36. Thrombosis in peripheral artery disease and thrombotic thrombocytopenia after adenoviral COVID-19 vaccination (2021). Eur Heart J [PubMed]
37. Predicted and Observed Incidence of Thromboembolic Events among Koreans Vaccinated with ChAdOx1 nCoV-19 Vaccine (2021). J Korean Med Sci [PubMed]
38. COVID-19 vaccine-associated acute cerebral venous thrombosis and pulmonary artery embolism (2021). QJM [PubMed]
39. Adjunct Immune Globulin for Vaccine-Induced Immune Thrombotic Thrombocytopenia (2021). N Engl J Med [PubMed]
40. Portal Vein Thrombosis due to Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) after Covid Vaccination with ChAdOx1 nCoV-19 (2021). Ultraschall Med [PubMed]
41. Immune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOx1 nCov-19) (2021). Blood [PubMed]
42. Petechial skin rash associated with CoronaVac vaccination: first cutaneous side effect report before phase 3 results (2021). Eur J Hosp Pharm [PubMed]
43. COVID-19 vaccine, immune thrombotic thrombocytopenia, jaundice, hyperviscosity: concern on cases with underlying liver problem (2021). Ann Hepatol [PubMed]
44. Cerebral Venous Sinus Thrombosis in the U.S. Population, After Adenovirus-Based SARS-CoV-2 Vaccination, and After COVID-19 (2021). J Am Coll Cardiol [PubMed]
45. Central Venous Sinus Thrombosis with Subarachnoid Hemorrhage Following an mRNA COVID-19 Vaccination: Are These Reports Merely Co-Incidental? (2021). Am J Case Rep [PubMed]
46. Fatal cerebral venous sinus thrombosis after COVID-19 vaccination (2021). Intensive Care Med [PubMed]
47. Prothrombotic immune thrombocytopenia after COVID-19 vaccination (2021). Blood [PubMed]
48. A rare case of COVID-19 vaccine-induced thrombotic thrombocytopaenia (VITT) involving the veno-splanchnic and pulmonary arterial circulation, from a UK district general hospital (2021). BMJ Case Rep [PubMed]
49. Idiopathic Ipsilateral External Jugular Vein Thrombophlebitis After Coronavirus Disease (COVID-19) Vaccination (2021). AJR Am J Roentgenol [PubMed]
50. Antiphospholipid antibodies and risk of post-COVID-19 vaccination thrombophilia: The straw that breaks the camel’s back? (2021). Cytokine Growth Factor Rev [PubMed]
51. Vaccine-Induced Immune Thrombotic Thrombocytopenia with Disseminated Intravascular Coagulation and Death following the ChAdOx1 nCoV-19 Vaccine (2021). J Stroke Cerebrovasc Dis [PubMed]
52. Acute Ischemic Stroke Revealing ChAdOx1 nCov-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia: Impact on Recanalization Strategy (2021). J Stroke Cerebrovasc Dis [PubMed]
53. Transient Thrombocytopenia With Glycoprotein-Specific Platelet Autoantibodies After Ad26.COV2.S Vaccination: A Case Report (2021). Ann Intern Med [PubMed]
54. Thrombocytopenia with acute ischemic stroke and bleeding in a patient newly vaccinated with an adenoviral vector-based COVID-19 vaccine (2021). J Thromb Haemost [PubMed]
55. Neurosurgical Considerations Regarding Decompressive Craniectomy for Intracerebral Hemorrhage after SARS-CoV-2-Vaccination in Vaccine Induced Thrombotic Thrombocytopenia-VITT (2021). J Clin Med [PubMed]
56. Anti-PF4 antibody negative cerebral venous sinus thrombosis without thrombocytopenia following immunization with COVID-19 vaccine in an elderly non-comorbid Indian male, managed with conventional heparin-warfarin based anticoagulation (2021). Diabetes Metab Syndr [PubMed]
57. Thromboses of major arteries and ChAdOx1 nCov-19 vaccination (2021). Neurol Res Pract [PubMed]
58. Oxford-AstraZeneca COVID-19 vaccine-induced cerebral venous thrombosis and thrombocytopaenia: A missed opportunity for a rapid return of experience (2021). Anaesth Crit Care Pain Med [PubMed]
59. Vaccination against COVID-19: insight from arterial and venous thrombosis occurrence using data from VigiBase (2021). Eur Respir J [PubMed]
60. Cerebral Venous Thrombosis after BNT162b2 mRNA SARS-CoV-2 vaccine (2021). J Stroke Cerebrovasc Dis [PubMed]
61. Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review (2021). J Neurol Sci [PubMed]
62. Case Report: Vaccine-Induced Immune Thrombotic Thrombocytopenia in a Pancreatic Cancer Patient After Vaccination With Messenger RNA-1273 (2021). Front Med (Lausanne) [PubMed]
63. Intracerebral Hemorrhage and Thrombocytopenia After AstraZeneca COVID-19 Vaccine: Clinical and Diagnostic Challenges of Vaccine-Induced Thrombotic Thrombocytopenia (2021). Cureus [PubMed]
64. Herpes-like skin lesion after AstraZeneca vaccination for COVID-19: A case report (2021). Clin Case Rep [PubMed]
65. An unusual presentation of acute deep vein thrombosis after the Moderna COVID-19 vaccine-a case report (2021). Ann Transl Med [PubMed]
66. Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study (2021). BMJ [PubMed]
67. Massive cerebral venous thrombosis and venous watershed infarction as late complications of COVID-19: a case report (2021). Neurol Sci [PubMed]
68. Intracerebral Hemorrhage due to Thrombosis with Thrombocytopenia Syndrome after Vaccination against COVID-19: the First Fatal Case in Korea (2021). J Korean Med Sci [PubMed]
69. Immediate high-dose intravenous immunoglobulins followed by direct thrombin-inhibitor treatment is crucial for survival in Sars-Covid-19-adenoviral vector vaccine-induced immune thrombotic thrombocytopenia VITT with cerebral sinus venous and portal vein thrombosis (2021). J Neurol [PubMed]
70. Reported adverse effects following COVID-19 vaccination at a tertiary care hospital, focus on cerebral venous sinus thrombosis (CVST) (2021). Expert Rev Vaccines [PubMed]
71. Management of cerebral and splanchnic vein thrombosis associated with thrombocytopenia in subjects previously vaccinated with Vaxzevria (AstraZeneca): a position statement from the Italian Society for the Study of Haemostasis and Thrombosis (SISET) (2021). Blood Transfus [PubMed]
72. Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study (2021). BMJ [PubMed]
73. A 59-Year-Old Woman with Extensive Deep Vein Thrombosis and Pulmonary Thromboembolism 7 Days Following a First Dose of the Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine (2021). Am J Case Rep [PubMed]
74. Thrombosis After Adenovirus-Vectored COVID-19 Vaccination: A Concern on Underlying Illness (2021). Clin Appl Thromb Hemost [PubMed]
75. COVID-19 vaccine-induced thrombosis (2021). Int J Tuberc Lung Dis [PubMed]
76. Inflammation and Platelet Activation After COVID-19 Vaccines – Possible Mechanisms Behind Vaccine-Induced Immune Thrombocytopenia and Thrombosis (2021). Front Immunol [PubMed]
77. Possible Risk of Thrombotic Events following Oxford-AstraZeneca COVID-19 Vaccination in Women Receiving Estrogen (2021). Biomed Res Int [PubMed]
78. Thromboaspiration and fibrinolysis infusion for portomesenteric thrombosis after AstraZeneca COVID-19 vaccine administration (2021). Intensive Care Med [PubMed]
79. Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis (2021). N Engl J Med [PubMed]
80. Deep Venous Thrombosis after Ad26.COV2.S Vaccination in Adult Male (2021). Case Rep Crit Care [PubMed]
81. Cerebral Venous Sinus Thrombosis, Pulmonary Embolism, and Thrombocytopenia After COVID-19 Vaccination in a Taiwanese Man: A Case Report and Literature Review (2021). Front Neurol [PubMed]
82. Deep vein thrombosis more than two weeks after vaccination against COVID-19 (2021). Tidsskr Nor Laegeforen [PubMed]
83. Complicated Long Term Vaccine Induced Thrombotic Immune Thrombocytopenia-A Case Report (2021). Vaccines (Basel) [PubMed]
84. Thrombotic thrombocytopenic purpura: a new menace after COVID bnt162b2 vaccine (2021). Int J Hematol [PubMed]
85. A COVID-Positive 52-Year-Old Man Presented With Venous Thromboembolism and Disseminated Intravascular Coagulation Following Johnson & Johnson Vaccination: A Case-Study (2021). Cureus [PubMed]
86. Cerebral Venous Sinus Thrombosis After Pfizer-BioNTech COVID-19 (BNT162b2) Vaccination (2021). J Clin Neurol [PubMed]
87. Malignant cerebral infarction after ChAdOx1 nCov-19 vaccination: a catastrophic variant of vaccine-induced immune thrombotic thrombocytopenia (2021). Nat Commun [PubMed]
88. Vaccine-induced thrombotic thrombocytopenia following Ad26.COV2.S vaccine in a man presenting as acute venous thromboembolism (2021). Am J Hematol [PubMed]
89. Limb ischemia and pulmonary artery thrombosis after the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine: a case of vaccine-induced immune thrombotic thrombocytopenia (2021). CMAJ [PubMed]
90. Understanding risk of thrombosis with thrombocytopenia syndrome after Ad26.COV2.S vaccination (2021). Front Med [PubMed]
91. Secondary immune thrombocytopenia supposedly attributable to COVID-19 vaccination (2021). BMJ Case Rep [PubMed]
92. Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine – United States, March-April 2021 (2021). MMWR Morb Mortal Wkly Rep [PubMed]
93. [Intracerebral haemorrhage twelve days after vaccination with ChAdOx1 nCoV-19] (2021). Ugeskr Laeger [PubMed]
94. Retinal Hemorrhage after SARS-CoV-2 Vaccination (2021). J Clin Med [PubMed]
95. Atypical thrombosis associated with VaxZevria® (AstraZeneca) vaccine: Data from the French Network of Regional Pharmacovigilance Centres (2021). Therapie [PubMed]
96. Acute Coronary Tree Thrombosis After Vaccination for COVID-19 (2021). JACC Cardiovasc Interv [PubMed]
97. Vaccine-Associated Thrombocytopenia and Thrombosis: Venous Endotheliopathy Leading to Venous Combined Micro-Macrothrombosis (2021). Medicina (Kaunas) [PubMed]
98. Thrombotic Thrombocytopenia after COVID-19 Vaccination: In Search of the Underlying Mechanism (2021). Vaccines (Basel) [PubMed]
99. A case of vaccine-induced immune thrombotic thrombocytopenia with massive artero-venous thrombosis (2021). Blood Transfus [PubMed]
100. Thrombosis With Thrombocytopenia After the Messenger RNA-1273 Vaccine (2021). Ann Intern Med [PubMed]
101. Cerebral venous sinus thrombosis 2 weeks after the first dose of mRNA SARS-CoV-2 vaccine (2021). Acta Neurochir (Wien) [PubMed]
102. US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021 (2021). JAMA [PubMed]
103. Thrombosis in pre- and post-vaccination phase of COVID-19 (2021). Eur Heart J Suppl [PubMed]
104. Portal vein thrombosis associated with ChAdOx1 nCov-19 vaccination (2021). Lancet Gastroenterol Hepatol [PubMed]
105. Immune thrombocytopenia following immunisation with Vaxzevria ChadOx1-S (AstraZeneca) vaccine, Victoria, Australia (2021). Vaccine [PubMed]
106. Procoagulant microparticles: a possible link between vaccine-induced immune thrombocytopenia (VITT) and cerebral sinus venous thrombosis (2021). J Thromb Thrombolysis [PubMed]
107. Comparison of vaccine-induced thrombotic events between ChAdOx1 nCoV-19 and Ad26.COV.2.S vaccines (2021). J Autoimmun [PubMed]
108. Vaccine-Induced Thrombocytopenia with Severe Headache (2021). N Engl J Med [PubMed]
109. Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination (2021). N Engl J Med [PubMed]
110. Aphasia seven days after second dose of an mRNA-based SARS-CoV-2 vaccine (2021). Brain Hemorrhages [PubMed]
111. Thrombotic Events after COVID-19 Vaccination in the Over-50s: Results from a Population-Based Study in Italy (2021). Vaccines (Basel) [PubMed]
112. Acute ST-segment elevation myocardial infarction secondary to vaccine-induced immune thrombosis with thrombocytopaenia (VITT) (2021). BMJ Case Rep [PubMed]
113. Covid-19 vaccine- induced thrombosis and thrombocytopenia-a commentary on an important and practical clinical dilemma (2021). Prog Cardiovasc Dis [PubMed]
114. Cerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination – A report of two UK cases (2021). Brain Behav Immun [PubMed]
115. A case of thrombocytopenia and multiple thromboses after vaccination with ChAdOx1 nCoV-19 against SARS-CoV-2 (2021). Blood Adv [PubMed]
116. [Cerebral vein/venous sinus thrombosis with thrombocytopenia syndrome after COVID-19 vaccination] (2021). Rinsho Shinkeigaku [PubMed]
117. Cerebral venous thrombosis post BNT162b2 mRNA SARS-CoV-2 vaccination: A black swan event (2021). Am J Hematol [PubMed]
118. Massive cerebral venous thrombosis due to vaccine-induced immune thrombotic thrombocytopenia (2021). Haematologica [PubMed]
119. Comments on Thrombosis After Vaccination: The Leader Sequence of the Spike Protein Might Be Responsible for Thrombosis and Antibody-Mediated Thrombocytopenia (2021). Viral Immunol [PubMed]
120. Platelet activation and modulation in thrombosis with thrombocytopenia syndrome associated with ChAdO×1 nCov-19 vaccine (2021). Haematologica [PubMed]
121. Cardiovascular, neurological, and pulmonary events following vaccination with the BNT162b2, ChAdOx1 nCoV-19, and Ad26.COV2.S vaccines: An analysis of European data (2021). J Autoimmun [PubMed]
122. Association between ChAdOx1 nCoV-19 vaccination and bleeding episodes: Large population-based cohort study (2021). Vaccine [PubMed]
123. Potential Triggers for Thrombocytopenia and/or Hemorrhage by the BNT162b2 Vaccine, Pfizer-BioNTech (2021). Front Med (Lausanne) [PubMed]
124. Renal Vein Thrombosis and Pulmonary Embolism Secondary to Vaccine-induced Thrombotic Thrombocytopenia (VITT) (2021). Eur J Case Rep Intern Med [PubMed]
125. SARS-CoV-2 vaccine-induced cerebral venous thrombosis (2021). Eur J Intern Med [PubMed]
126. COVID-19 Vaccine-Associated Thrombosis With Thrombocytopenia Syndrome (TTS): A Systematic Review and Post Hoc Analysis (2021). Clin Appl Thromb Hemost [PubMed]
127. Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination (2021). Am J Hematol [PubMed]
128. Cerebral Venous Sinus Thrombosis and Thrombotic Events After Vector-Based COVID-19 Vaccines: A Systematic Review and Meta-analysis (2021). Neurology [PubMed]
129. Thrombotic Thrombocytopenic Purpura after Ad26.COV2-S Vaccination (2021). Am J Emerg Med [PubMed]
130. Immune thrombocytopenia relapse post covid-19 vaccine in young male patient (2021). IDCases [PubMed]
131. Petechiae and Desquamation of Fingers Following Immunization With BTN162b2 Messenger RNA (mRNA) COVID-19 Vaccine (2021). Cureus [PubMed]
132. Primary adrenal insufficiency associated with Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia (VITT) (2021). Eur J Intern Med [PubMed]
133. Cerebral venous sinus thrombosis associated with thrombocytopenia post-vaccination for COVID-19 (2021). Crit Care [PubMed]
134. COVID-19 vaccine-induced immune thrombotic thrombocytopenia: An emerging cause of splanchnic vein thrombosis (2021). Ann Hepatol [PubMed]
135. Lobar bleeding with ventricular rupture shortly after first dosage of an mRNA-based SARS-CoV-2 vaccine (2021). Brain Hemorrhages [PubMed]
136. Endovascular treatment for vaccine-induced cerebral venous sinus thrombosis and thrombocytopenia following ChAdOx1 nCoV-19 vaccination: a report of three cases (2021). J Neurointerv Surg [PubMed]
137. Australian and New Zealand approach to diagnosis and management of vaccine-induced immune thrombosis and thrombocytopenia (2021). Med J Aust [PubMed]
138. Thrombosis with Thrombocytopenia Syndrome associated with viral vector COVID-19 vaccines (2021). Eur J Intern Med [PubMed]
139. Rare case of COVID-19 vaccine-associated intracranial haemorrhage with venous sinus thrombosis (2021). BMJ Case Rep [PubMed]
140. Antibody-mediated procoagulant platelets in SARS-CoV-2-vaccination associated immune thrombotic thrombocytopenia (2021). Haematologica [PubMed]
141. Thrombocytopenia in a teen with sickle cell disease following COVID-19 vaccination (2021). Pediatr Blood Cancer [PubMed]
142. Pulmonary embolism, transient ischaemic attack and thrombocytopenia after the Johnson & Johnson COVID-19 vaccine (2021). BMJ Case Rep [PubMed]
143. Immune-Mediated Thrombocytopenia Associated With Ad26.COV2.S (Janssen; Johnson & Johnson) Vaccine (2021). Am J Ther [PubMed]
144. Vaccine induced thrombotic thrombocytopenia: The shady chapter of a success story (2021). Metabol Open [PubMed]
145. Cerebral venous sinus thrombosis after vaccination: the UK experience (2021). Lancet [PubMed]
146. Cerebral Venous Sinus Thrombosis After BNT162b2 mRNA COVID-19 Vaccination (2021). Cureus [PubMed]
147. Treatment of ChAdOx1 nCoV-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia Related Acute Ischemic Stroke (2021). J Stroke Cerebrovasc Dis [PubMed]
148. A Rare Case of Cerebral Venous Thrombosis and Disseminated Intravascular Coagulation Temporally Associated to the COVID-19 Vaccine Administration (2021). J Pers Med [PubMed]
149. Immune Thrombocytopenic Purpura Following Pfizer-BioNTech COVID-19 Vaccine in an Elderly Female (2021). Cureus [PubMed]
150. Adenovirus-Vectored COVID-19 Vaccine-Induced Immune Thrombosis of Carotid Artery: A Case Report (2021). Neurology [PubMed]
151. Immune thrombocytopenia following vaccination during the COVID-19 pandemic (2021). Haematologica [PubMed]
152. COVID 19 vaccine in patients of hypercoagulable disorders: a clinical perspective (2021). Horm Mol Biol Clin Investig [PubMed]
153. New Portal Vein Thrombosis in Cirrhosis-is the thrombophilia exacerbated due to Vaccine or COVID-19? (2021). J Clin Exp Hepatol [PubMed]
154. Post-SARS-CoV-2-vaccination cerebral venous sinus thrombosis: an analysis of cases notified to the European Medicines Agency (2021). Eur J Neurol [PubMed]
155. Severe, Refractory Immune Thrombocytopenia Occurring After SARS-CoV-2 Vaccine (2021). J Blood Med [PubMed]
156. Deep vein thrombosis (DVT) occurring shortly after the second dose of mRNA SARS-CoV-2 vaccine (2021). Intern Emerg Med [PubMed]
157. Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines (2021). Am J Emerg Med [PubMed]
158. PF4 Immunoassays in Vaccine-Induced Thrombotic Thrombocytopenia (2021). N Engl J Med [PubMed]
159. COVID-19 vaccine-associated immune thrombosis and thrombocytopenia (VITT): Diagnostic and therapeutic recommendations for a new syndrome (2021). Eur J Haematol [PubMed]
160. Cutaneous thrombosis associated with skin necrosis following Oxford-AstraZeneca COVID-19 vaccination (2021). Clin Exp Dermatol [PubMed]
161. Neuro-ophthalmic complications with ChAdOx1 nCoV-19 vaccine-induced thrombocytopenia and thrombosis (2021). Br J Hosp Med (Lond) [PubMed]
162. SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia (2021). N Engl J Med [PubMed]
163. Severe immune thrombocytopenic purpura after SARS-CoV-2 vaccine (2021). Arch Clin Cases [PubMed]
164. Diffuse prothrombotic syndrome after ChAdOx1 nCoV-19 vaccine administration: a case report (2021). J Med Case Rep [PubMed]
165. Immune Thrombocytopenia Following the Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine (2021). Isr Med Assoc J [PubMed]
166. COVID-19 Vaccine-Associated Cerebral Venous Thrombosis in Germany (2021). Ann Neurol [PubMed]
167. Delayed headache after COVID-19 vaccination: a red flag for vaccine induced cerebral venous thrombosis (2021). J Headache Pain [PubMed]
168. Thrombocytopenia after COVID-19 vaccination (2021). J Autoimmun [PubMed]
169. Vaccine-induced thrombosis and thrombocytopenia with bilateral adrenal haemorrhage (2021). Clin Endocrinol (Oxf) [PubMed]
170. Vaccine-induced immune thrombosis and thrombocytopenia syndrome following adenovirus-vectored severe acute respiratory syndrome coronavirus 2 vaccination: a novel hypothesis regarding mechanisms and implications for future vaccine development (2021). Immunol Cell Biol [PubMed]
171. Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination (2021). Lancet [PubMed]
172. A Case of Acute Pulmonary Embolus after mRNA SARS-CoV-2 Immunization (2021). Vaccines (Basel) [PubMed]
173. COVID-19 Vaccine-Induced Thrombotic Thrombocytopenia: A Case Series (2021). Cureus [PubMed]
174. Spontaneous HIT syndrome: Knee replacement, infection, and parallels with vaccine-induced immune thrombotic thrombocytopenia (2021). Thromb Res [PubMed]
175. Immune thrombocytopenia in a 22-year-old post Covid-19 vaccine (2021). Am J Hematol [PubMed]
176. The International Cerebral Venous Thrombosis Consortium report on cerebral venous thrombosis following vaccination against SARS-CoV-2 (2021). Eur J Neurol [PubMed]
177. Post-mortem findings in vaccine-induced thrombotic thombocytopenia (2021). Haematologica [PubMed]
178. Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination (2021). N Engl J Med [PubMed]
179. [Diagnostic and treatment recommendations from the FACME ad-hoc expert working group on the management of cerebral venous sinus thrombosis associated with COVID-19 vaccination] (2021). Neurologia [PubMed]
180. Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT): Targeting Pathomechanisms with Bruton Tyrosine Kinase Inhibitors (2021). Thromb Haemost [PubMed]
181. Vaccine-induced thrombotic thrombocytopenia: the elusive link between thrombosis and adenovirus-based SARS-CoV-2 vaccines (2021). Intern Emerg Med [PubMed]
182. A Case of Idiopathic Thrombocytopenic Purpura After Booster Dose of BNT162b2 (Pfizer-Biontech) COVID-19 Vaccine (2021). Cureus [PubMed]
183. VITT after ChAdOx1 nCoV-19 Vaccination (2021). N Engl J Med [PubMed]
184. Myocardial Infarction and Azygos Vein Thrombosis After ChAdOx1 nCoV-19 Vaccination in a Hemodialysis Patient (2021). Cureus [PubMed]
185. A Rare Case of Superior Ophthalmic Vein Thrombosis and Thrombocytopenia Following ChAdOx1 nCoV-19 Vaccine Against SARS-CoV-2 (2021). Mediterr J Hematol Infect Dis [PubMed]
186. Venous Thromboembolism and Mild Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination (2021). Thromb Haemost [PubMed]
187. A Case Report of Immune Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination (2021). J Korean Med Sci [PubMed]
188. Mechanisms of Immunothrombosis in Vaccine-Induced Thrombotic Thrombocytopenia (VITT) Compared to Natural SARS-CoV-2 Infection (2021). J Autoimmun [PubMed]
189. Thromboembolic events in younger women exposed to Pfizer-BioNTech or Moderna COVID-19 vaccines (2021). Expert Opin Drug Saf [PubMed]
190. Immune thrombocytopenia associated with Pfizer-BioNTech’s BNT162b2 mRNA COVID-19 vaccine (2021). IDCases [PubMed]
191. Vaccine-induced immune thrombotic thrombocytopenia (VITT) – a novel clinico-pathological entity with heterogeneous clinical presentations (2021). Br J Haematol [PubMed]
192. Thrombosis with thrombocytopenia syndrome after COVID-19 vaccination (2021). Clin Adv Hematol Oncol [PubMed]
193. Immune thrombocytopenic purpura and acute liver injury after COVID-19 vaccine (2021). BMJ Case Rep [PubMed]
194. Ischaemic stroke as a presenting feature of ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia (2021). J Neurol Neurosurg Psychiatry [PubMed]
195. Purpuric Rash and Thrombocytopenia After the mRNA-1273 (Moderna) COVID-19 Vaccine (2021). Cureus [PubMed]
196. Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia (2021). Nature [PubMed]
197. Immune complexes, innate immunity, and NETosis in ChAdOx1 vaccine-induced thrombocytopenia (2021). Eur Heart J [PubMed]
198. Concern About the Adverse Effects of Thrombocytopenia and Thrombosis After Adenovirus-Vectored COVID-19 Vaccination (2021). Clin Appl Thromb Hemost [PubMed]
199. Symptomatic peduncular, cavernous bleeding following SARS-CoV-2 vaccination induced immune thrombocytopenia (2021). Brain Hemorrhages [PubMed]
200. Large hemorrhagic stroke after ChAdOx1 nCoV-19 vaccination: A case report (2021). Acta Neurol Scand [PubMed]
201. Laboratory testing for suspected COVID-19 vaccine-induced (immune) thrombotic thrombocytopenia (2021). Int J Lab Hematol [PubMed]
202. mRNA COVID-19 Vaccine-Related Anaphylactoid Reaction and Coronary Thrombosis (2021). Mayo Clin Proc [PubMed]
203. Thrombocytopenia and splanchnic thrombosis after Ad26.COV2.S vaccination successfully treated with transjugular intrahepatic portosystemic shunting and thrombectomy (2021). Am J Hematol [PubMed]
204. Venous sinus thrombosis following vaccination with ChAdOx1 nCov-19 (2021). Med Intensiva (Engl Ed) [PubMed]
205. Vaccine-induced severe thrombotic thrombocytopenia following COVID-19 vaccination: a report of an autoptic case and review of the literature (2021). Eur Rev Med Pharmacol Sci [PubMed]
206. Idiopathic Thrombocytopenic Purpura and the Moderna Covid-19 Vaccine (2021). Ann Emerg Med [PubMed]
207. Exacerbation of immune thrombocytopenia following COVID-19 vaccination (2021). Br J Haematol [PubMed]
208. Vaccine Induced Immune Thrombotic Thrombocytopenia Causing a Severe Form of Cerebral Venous Thrombosis With High Fatality Rate: A Case Series (2021). Front Neurol [PubMed]
209. Change of blood viscosity after COVID-19 vaccination: estimation for persons with underlying metabolic syndrome (2021). Int J Physiol Pathophysiol Pharmacol [PubMed]
210. Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia (2021). Blood [PubMed]
211. Thrombosis post COVID-19 vaccinations: Potential link to ACE pathways (2021). Thromb Res [PubMed]
212. First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland (2021). Nat Med [PubMed]
213. [Cerebral venous sinus thrombosis after COVID-19 vaccination : Neurological and radiological management] (2021). Radiologe [PubMed]
214. Coeliac artery and splenic artery thrombosis complicated with splenic infarction 7 days following the first dose of Oxford vaccination, causal relationship or coincidence? (2021). BMJ Case Rep [PubMed]
215. Immune thrombocytopenic purpura associated with COVID-19 Pfizer-BioNTech BNT16B2b2 mRNA vaccine (2021). J Eur Acad Dermatol Venereol [PubMed]
216. Newly Diagnosed Idiopathic Thrombocytopenia Post COVID-19 Vaccine Administration (2021). Cureus [PubMed]
217. Thrombosis and severe acute respiratory syndrome coronavirus 2 vaccines: vaccine-induced immune thrombotic thrombocytopenia (2021). Clin Exp Pediatr [PubMed]
218. Interactions of adenoviruses with platelets and coagulation and the vaccine-induced immune thrombotic thrombocytopenia syndrome (2021). Haematologica [PubMed]
219. Thrombocytopenia and Intracranial Venous Sinus Thrombosis after “COVID-19 Vaccine AstraZeneca” Exposure (2021). J Clin Med [PubMed]
220. Severe immune thrombocytopenia after COVID-19 vaccination: Report of four cases and review of the literature (2021). Blood Cells Mol Dis [PubMed]
221. Fatal exacerbation of ChadOx1-nCoV-19-induced thrombotic thrombocytopenia syndrome after initial successful therapy with intravenous immunoglobulins – a rational for monitoring immunoglobulin G levels (2021). Haematologica [PubMed]
222. Diagnosis and Management of Cerebral Venous Sinus Thrombosis With Vaccine-Induced Immune Thrombotic Thrombocytopenia (2021). Stroke [PubMed]
223. Early Outcomes of Bivalirudin Therapy for Thrombotic Thrombocytopenia and Cerebral Venous Sinus Thrombosis After Ad26.COV2.S Vaccination (2021). Ann Emerg Med [PubMed]
224. Coagulopathies after Vaccination against SARS-CoV-2 May Be Derived from a Combined Effect of SARS-CoV-2 Spike Protein and Adenovirus Vector-Triggered Signaling Pathways (2021). Int J Mol Sci [PubMed]
225. The importance of recognizing cerebral venous thrombosis following anti-COVID-19 vaccination (2021). Eur J Intern Med [PubMed]
226. Fatal cerebral haemorrhage after COVID-19 vaccine (2021). Tidsskr Nor Laegeforen [PubMed]
227. Prevalence of thrombocytopenia, anti-platelet factor 4 antibodies and D-dimer elevation in Thai people After ChAdOx1 nCoV-19 vaccination (2021). Res Pract Thromb Haemost [PubMed]
228. Bilateral Thalamic Stroke: A Case of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) or a Coincidence Due to Underlying Risk Factors? (2021). Cureus [PubMed]
229. Management of a patient with a rare congenital limb malformation syndrome after SARS-CoV-2 vaccine-induced thrombosis and thrombocytopenia (VITT) (2021). Br J Haematol [PubMed]
230. Acute Ischaemic Stroke Incidence after Coronavirus Vaccine in Indonesia: Case Series (2021). Curr Neurovasc Res [PubMed]
231. Vaccine-induced thrombotic thrombocytopenia, a rare but severe case of friendly fire in the battle against COVID-19 pandemic: What pathogenesis? (2021). Eur J Intern Med [PubMed]
232. Comparison of adverse drug reactions among four COVID-19 vaccines in Europe using the EudraVigilance database: Thrombosis at unusual sites (2021). J Thromb Haemost [PubMed]
233. Cerebral venous thrombosis after COVID-19 vaccination: is the risk of thrombosis increased by intravascular application of the vaccine? (2021). Infection [PubMed]
234. Secondary Immune Thrombocytopenia (ITP) Associated with ChAdOx1 Covid-19 Vaccination – A Case Report (2021). TH Open [PubMed]
235. Cerebral venous sinus thrombosis after ChAdOx1 nCov-19 vaccination with a misleading first cerebral MRI scan (2021). Stroke Vasc Neurol [PubMed]
236. Isolated pulmonary embolism following COVID vaccination: 2 case reports and a review of post-acute pulmonary embolism complications and follow-up (2021). J Community Hosp Intern Med Perspect [PubMed]
237. Cerebral venous sinus thrombosis after ChAdOx1 vaccination: the first case of definite thrombosis with thrombocytopenia syndrome from India (2021). BMJ Case Rep [PubMed]
238. ChAdOx1 interacts with CAR and PF4 with implications for thrombosis with thrombocytopenia syndrome (2021). Sci Adv [PubMed]
239. Case study of thrombosis and thrombocytopenia syndrome following administration of the AstraZeneca COVID-19 vaccine (2021). Aust J Gen Pract [PubMed]
240. Blood clots and bleeding events following BNT162b2 and ChAdOx1 nCoV-19 vaccine: An analysis of European data (2021). J Autoimmun [PubMed]
241. Thrombotic Adverse Events Reported for Moderna, Pfizer and Oxford-AstraZeneca COVID-19 Vaccines: Comparison of Occurrence and Clinical Outcomes in the EudraVigilance Database (2021). Vaccines (Basel) [PubMed]
242. Cerebral venous thrombosis and thrombocytopenia post-COVID-19 vaccination (2021). Thromb Res [PubMed]
243. Thrombosis with Thrombocytopenia Syndrome (TTS) following AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19 vaccination – A risk-benefit analysis for people < 60 years in Australia (2021). Vaccine [PubMed]
244. Hypotheses behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccination (2021). Thromb Res [PubMed]
245. Predictors of mortality in thrombotic thrombocytopenia after adenoviral COVID-19 vaccination: the FAPIC score (2021). Eur Heart J [PubMed]
246. [Acral haemorrhage after the second dose administration of SARS-CoV-2 vaccine. A post-vaccinal reaction?] (2021). Med Clin (Barc) [PubMed]
247. Cerebral Venous Thrombosis following COVID-19 Vaccination (2021). J Stroke Cerebrovasc Dis [PubMed]
248. Imaging of Oxford/AstraZeneca® COVID-19 vaccine-induced immune thrombotic thrombocytopenia (2021). Diagn Interv Imaging [PubMed]
249. Case Report: Take a Second Look: Covid-19 Vaccination-Related Cerebral Venous Thrombosis and Thrombotic Thrombocytopenia Syndrome (2021). Front Neurol [PubMed]
250. Acquired thrombotic thrombocytopenic purpura: A rare disease associated with BNT162b2 vaccine (2021). J Thromb Haemost [PubMed]
251. Autoimmunity roots of the thrombotic events after COVID-19 vaccination (2021). Autoimmun Rev [PubMed]
252. Thrombosis of the palmar digital vein after Oxford-AstraZeneca COVID-19 vaccination (2021). Int J Dermatol [PubMed]
253. Post-COVID-19 vaccination occurrence of splenic infarction due to arterial thrombosis (2021). BMJ Case Rep [PubMed]
254. Type 1 Kounis Syndrome Induced by Inactivated SARS-COV-2 Vaccine (2021). J Emerg Med [PubMed]

Vasculitis, including Henoch-Schonlein purpura

Vasculitis is an inflammation of the blood vessels that can cause thrombosis and be life-threatening.

1. Images in Vascular Medicine: Leukocytoclastic vasculitis after COVID-19 vaccine booster (2022). Vasc Med [PubMed]
2. Leukocytoclastic vasculitis after exposure to COVID-19 vaccine (2022). An Bras Dermatol [PubMed]
3. Relapsed ANCA associated vasculitis following Oxford AstraZeneca ChAdOx1-S COVID-19 vaccination: A case series of two patients (2022). Nephrology (Carlton) [PubMed]
4. A case of generalized Sweet syndrome with vasculitis triggered by recent COVID-19 vaccination (2022). JAAD Case Rep [PubMed]
5. Flares of mixed cryoglobulinaemia vasculitis after vaccination against SARS-CoV-2 (2022). Ann Rheum Dis [PubMed]
6. Post-COVID-19 vaccination IgA vasculitis in an adult (2022). J Cutan Pathol [PubMed]
7. Leukocytoclastic vasculitis after coronavirus disease 2019 vaccination (2022). J Dermatol [PubMed]
8. Cutaneous Lymphocytic Vasculitis After Administration of the Second Dose of AZD1222 (Oxford-AstraZeneca) Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination: Casuality or Causality? (2022). Am J Dermatopathol [PubMed]
9. Intracerebral hemorrhage due to vasculitis following COVID-19 vaccination: a case report (2022). Acta Neurochir (Wien) [PubMed]
10. Vasculitis and bursitis on [18F]FDG-PET/CT following COVID-19 mRNA vaccine: post hoc ergo propter hoc? (2022). Eur J Nucl Med Mol Imaging [PubMed]
11. Possible case of mRNA COVID-19 vaccine-induced small-vessel vasculitis (2022). J Cosmet Dermatol [PubMed]
12. Case Report: Anti-neutrophil Cytoplasmic Antibody-Associated Vasculitis With Acute Renal Failure and Pulmonary Hemorrhage May Occur After COVID-19 Vaccination (2021). Front Med (Lausanne) [PubMed]
13. Case of immunoglobulin A vasculitis following coronavirus disease 2019 vaccination (2021). J Dermatol [PubMed]
14. COVID-19 vaccine-induced urticarial vasculitis (2021). Dermatol Ther [PubMed]
15. Relapse of microscopic polyangiitis after vaccination against COVID-19: A case report (2021). J Med Virol [PubMed]
16. Cutaneous small vessel vasculitis following single-dose Janssen Ad26.COV2.S vaccination (2021). JAAD Case Rep [PubMed]
17. Henoch-Schönlein purpura presenting post COVID-19 vaccination (2021). Vaccine [PubMed]
18. New-onset leukocytoclastic vasculitis after COVID-19 vaccine (2021). Int J Dermatol [PubMed]
19. Cutaneous lymphocytic vasculitis after administration of COVID-19 mRNA vaccine (2021). Dermatol Ther [PubMed]
20. Cutaneous vasculitis after severe acute respiratory syndrome coronavirus 2 vaccine (2021). Rheumatol Adv Pract [PubMed]
21. Granulomatous vasculitis after the AstraZeneca anti-SARS-CoV-2 vaccine (2021). Kidney Int [PubMed]
22. Leukocytoclastic vasculitis flare following the COVID-19 vaccine (2021). Int J Dermatol [PubMed]
23. Emergence of de novo cutaneous vasculitis post coronavirus disease (COVID-19) vaccination (2021). Clin Rheumatol [PubMed]
24. Henoch-Schönlein Purpura Following the First Dose of COVID-19 Viral Vector Vaccine: A Case Report (2021). Vaccines (Basel) [PubMed]
25. Sinovac COVID-19 vaccine-induced cutaneous leukocytoclastic vasculitis (2021). JAAD Case Rep [PubMed]
26. Coronavirus disease 2019 (COVID-19) vaccination in systemic lupus erythematosus and anti-neutrophil cytoplasmic antibody-associated vasculitis (2021). Clin Rheumatol [PubMed]
27. Leukocytoclastic vasculitis as a cutaneous manifestation of ChAdOx1 nCoV-19 corona virus vaccine (recombinant) (2021). Dermatol Ther [PubMed]
28. Leukocytoclastic Vasculitis After Vaccination With a SARS-CoV-2 Vaccine (2021). Arthritis Rheumatol [PubMed]
29. Nephrotic syndrome and vasculitis following SARS-CoV-2 vaccine: true association or circumstantial? (2021). Nephrol Dial Transplant [PubMed]
30. Asymmetrical cutaneous vasculitis following COVID-19 vaccination with unusual eosinophil preponderance (2021). Clin Exp Dermatol [PubMed]
31. Cutaneous small-vessel vasculitis following COVID-19 vaccine (2021). J Cosmet Dermatol [PubMed]
32. IgA vasculitis in adult patient following vaccination by ChadOx1 nCoV-19 (2021). Autoimmun Rev [PubMed]
33. First description of immune complex vasculitis after COVID-19 vaccination with BNT162b2: a case report (2021). BMC Infect Dis [PubMed]
34. A case of ANCA-associated vasculitis after AZD1222 (Oxford-AstraZeneca) SARS-CoV-2 vaccination: casualty or causality? (2021). Kidney Int [PubMed]
35. Cutaneous vasculitis following COVID-19 vaccination (2021). Lancet Rheumatol [PubMed]
36. A Rare Case of Henoch-Schönlein Purpura Following a COVID-19 Vaccine-Case Report (2021). SN Compr Clin Med [PubMed]
37. Cutaneous Leukocytoclastic Vasculitis Induction Following ChAdOx1 nCoV-19 Vaccine (2021). Cureus [PubMed]
38. ANCA-Associated Vasculitis Following Pfizer-BioNTech COVID-19 Vaccine (2021). Am J Kidney Dis [PubMed]
39. Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis after COVID-19 Vaccination (2021). Vaccines (Basel) [PubMed]
40. Small vessel vasculitis related to varicella-zoster virus after Pfizer-BioNTech COVID-19 vaccine (2021). J Eur Acad Dermatol Venereol [PubMed]
41. Reactivation of IgA vasculitis following COVID-19 vaccination (2021). BMJ Case Rep [PubMed]
42. Small-vessel vasculitis following Oxford-AstraZeneca vaccination against SARS-CoV-2 (2021). J Eur Acad Dermatol Venereol [PubMed]
43. Reactivation of IgA vasculitis after COVID-19 vaccination (2021). Lancet Rheumatol [PubMed]

Neurology

Guillain-Barré Syndrome (GBS)

A neurological disorder in which the body’s immune system mistakenly attacks part of the peripheral nervous system — the network of nerves located outside of the brain and spinal cord. GBS can range from a very mild case with brief weakness to nearly devastating paralysis, leaving the person unable to breathe independently. Fortunately, many people recover from even the most severe cases of GBS. After recovery, some people will continue to have some degree of weakness.

1. A case of sensory ataxic Guillain-Barré syndrome with immunoglobulin G anti-GM1 antibodies following the first dose of mRNA COVID-19 vaccine BNT162b2 (Pfizer) (2022). QJM [PubMed]
2. Bilateral facial weakness with paraesthesia variant of Guillain-Barré syndrome following Vaxzevria COVID-19 vaccine (2022). J Neurol Neurosurg Psychiatry [PubMed]
3. Adenovirus COVID-19 Vaccines and Guillain-Barré Syndrome with Facial Paralysis (2022). Ann Neurol [PubMed]
4. Guillain-Barré Syndrome After COVID-19 Vaccination in an Adolescent (2022). Pediatr Neurol [PubMed]
5. Miller Fisher syndrome following Pfizer COVID-19 vaccine (2022). Neurol Sci [PubMed]
6. Guillain-Barré syndrome following the first dose of Pfizer-BioNTech COVID-19 vaccine: case report and review of reported cases (2022). Neurol Sci [PubMed]
7. Guillain-Barré Syndrome following ChAdOx1-S/nCoV-19 Vaccine (2021). Ann Neurol [PubMed]
8. Guillain-Barré Syndrome Presenting as Facial Diplegia after COVID-19 Vaccination: A Case Report (2021). J Emerg Med [PubMed]
9. Neurological Complications of COVID-19: Guillain-Barre Syndrome Following Pfizer COVID-19 Vaccine (2021). Cureus [PubMed]
10. Guillain-​Barré Syndrome Associated with COVID-19 Vaccination (2021). Emerg Infect Dis [PubMed]
11. [Guillian Barré syndromeafter mRNA-1273 vaccination against COVID-19] (2021). Ugeskr Laeger [PubMed]
12. Guillan-Barré Syndrome after First Vaccination Dose against COVID-19: Case Report (2021). Acta Medica (Hradec Kralove) [PubMed]
13. A Novel Case of Bifacial Diplegia Variant of Guillain-Barré Syndrome Following Janssen COVID-19 Vaccination (2021). Neurol Int [PubMed]
14. [COVID-19, Guillain-Barré syndrome, and the vaccine. A dangerous combination] (2021). Rev Clin Esp [PubMed]
15. GM1 ganglioside antibody and COVID-19 related Guillain Barre Syndrome – A case report, systemic review and implication for vaccine development (2021). Brain Behav Immun Health [PubMed]
16. Rate of Recurrent Guillain-Barré Syndrome After mRNA COVID-19 Vaccine BNT162b2 (2021). JAMA Neurol [PubMed]
17. Post SARS-CoV-2 vaccination Guillain-Barre syndrome in 19 patients (2021). Clinics (Sao Paulo) [PubMed]
18. Axonal-Variant Guillian-Barre Syndrome Temporally Associated With mRNA-Based Moderna SARS-CoV-2 Vaccine (2021). Cureus [PubMed]
19. Guillain-Barré syndrome after AstraZeneca COVID-19-vaccination: A causal or casual association? (2021). Clin Neurol Neurosurg [PubMed]
20. Guillain-Barré syndrome after SARS-CoV-2 vaccination in a patient with previous vaccine-associated Guillain-Barré syndrome (2021). CMAJ [PubMed]
21. Guillain-Barré syndrome following ChAdOx1 nCoV-19 COVID-19 vaccination: A case series (2021). Neurol Clin Neurosci [PubMed]
22. Guillain-Barré syndrome following first injection of ChAdOx1 nCoV-19 vaccine: First report (2021). Rev Neurol (Paris) [PubMed]
23. A Rare Variant of Guillain-Barre Syndrome Following Ad26.COV2.S Vaccination (2021). Cureus [PubMed]
24. SARS-CoV-2 vaccinations may not only be complicated by GBS but also by distal small fibre neuropathy (2021). J Neuroimmunol [PubMed]
25. Facial Diplegia: A Rare, Atypical Variant of Guillain-Barré Syndrome and Ad26.COV2.S Vaccine (2021). Cureus [PubMed]
26. Guillain-Barré syndrome following the first dose of SARS-CoV-2 vaccine: A temporal occurrence, not a causal association (2021). IDCases [PubMed]
27. Association of Receipt of the Ad26.COV2.S COVID-19 Vaccine With Presumptive Guillain-Barré Syndrome, February-July 2021 (2021). JAMA [PubMed]
28. A case of Guillain-Barre syndrome following Pfizer COVID-19 vaccine (2021). J Community Hosp Intern Med Perspect [PubMed]
29. A variant of Guillain-Barre syndrome after SARS-CoV-2 vaccination: AMSAN (2021). Ideggyogy Sz [PubMed]
30. Guillain-Barré Syndrome Variant Occurring after SARS-CoV-2 Vaccination (2021). Ann Neurol [PubMed]
31. Guillain-Barré syndrome following BNT162b2 COVID-19 vaccine (2021). Neurol Sci [PubMed]
32. Sensory Guillain-Barre syndrome following the ChAdOx1 nCov-19 vaccine: Report of two cases and review of literature (2021). J Neuroimmunol [PubMed]
33. COVID-19 vaccine causing Guillain-Barre syndrome, a rare potential side effect (2021). Clin Case Rep [PubMed]
34. Clinical Variant of Guillain-Barre Syndrome With Prominent Facial Diplegia After AstraZeneca Coronavirus Disease 2019 Vaccine (2021). J Clin Neuromuscul Dis [PubMed]
35. Guillain-Barrè syndrome following COVID-19 vaccine mRNA-1273: a case report (2021). Acta Neurol Belg [PubMed]
36. Guillain-Barré Syndrome in an Australian State Using Both mRNA and Adenovirus-Vector SARS-CoV-2 Vaccines (2021). Ann Neurol [PubMed]
37. SARS-CoV-2 vaccinations are unsafe for those experiencing post-vaccination Guillain-Barre syndrome (2021). Ann Med Surg (Lond) [PubMed]
38. A Rare Case of Guillain-Barré Syndrome following COVID-19 Vaccination (2021). Eur J Case Rep Intern Med [PubMed]
39. Guillain-Barré syndrome presenting with facial diplegia following COVID-19 vaccination in two patients (2021). BMJ Case Rep [PubMed]
40. Miller-Fisher Syndrome and Guillain-Barre Syndrome overlap syndrome in a patient post Oxford-AstraZeneca SARS-CoV-2 vaccination (2021). BMJ Case Rep [PubMed]
41. AstraZeneca COVID-19 vaccine and Guillain- Barré Syndrome in Tasmania: A causal link? (2021). J Neuroimmunol [PubMed]

Facial nerve palsy

This is an immune attack on the nerves that move the muscles of the upper and lower parts of the face. People will often have weakness on one side of the face.

1. Bell’s palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study (2022). Lancet Infect Dis [PubMed]
2. Bell’s palsy following a single dose of mRNA SARS-CoV-2 vaccine: a case report (2022). J Neurol [PubMed]
3. Left Bell’s palsy following the first dose of mRNA-1273 SARS-CoV-2 vaccine: A case report (2022). Clin Imaging [PubMed]
4. The association between COVID-19 vaccination and Bell’s palsy (2022). Lancet Infect Dis [PubMed]
5. Facial nerve palsy following the administration of COVID-19 mRNA vaccines: analysis of a self-reporting database (2021). Int J Infect Dis [PubMed]
6. Bell’s palsy and SARS-CoV-2 vaccines-an unfolding story (2021). Lancet Infect Dis [PubMed]
7. Sequential contralateral facial nerve palsies following COVID-19 vaccination first and second doses (2021). BMJ Case Rep [PubMed]
8. A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV-19 vaccine (2021). Neurol Sci [PubMed]
9. Bell’s Palsy after second dose of Pfizer COVID-19 vaccination in a patient with history of recurrent Bell’s palsy (2021). Brain Behav Immun Health [PubMed]
10. Bilateral Facial Nerve Palsy and COVID-19 Vaccination: Causation or Coincidence? (2021). Cureus [PubMed]
11. Bell’s palsy after inactivated COVID-19 vaccination in a patient with history of recurrent Bell’s palsy: A case report (2021). World J Clin Cases [PubMed]
12. Bell’s palsy following the Ad26.COV2.S COVID-19 vaccination (2021). QJM [PubMed]
13. Bell’s palsy following COVID-19 vaccination (2021). J Neurol [PubMed]
14. Bell’s palsy following COVID-19 vaccination: a case report (2021). Neurologia (Engl Ed) [PubMed]
15. Peripheral Facial Nerve Palsy Following BNT162b2 (COVID-19) Vaccination (2021). Isr Med Assoc J [PubMed]
16. Association of COVID-19 Vaccination and Facial Nerve Palsy: A Case-Control Study (2021). JAMA Otolaryngol Head Neck Surg [PubMed]
17. [Acute facial paresis as a possible complication of vaccination against SARS-CoV-2] (2021). Laryngorhinootologie [PubMed]
18. Adverse event reporting and Bell’s palsy risk after COVID-19 vaccination (2021). Lancet Infect Dis [PubMed]
19. Bell’s Palsy After 24 Hours of mRNA-1273 SARS-CoV-2 Vaccine (2021). Cureus [PubMed]
20. Type I interferons as the potential mechanism linking mRNA COVID-19 vaccines to Bell’s palsy (2021). Therapie [PubMed]
21. Bell’s palsy following COVID-19 vaccination with high CSF antibody response (2021). Neurol Sci [PubMed]

Acute myelitis, neuromyelitis, inflammatory neuropathy

These conditions are immune or inflammatory attacks on the spinal cord or brain that can cause paralysis.

1. Acute transverse myelitis following SARS-CoV-2 vaccination: a case report and review of literature (2022). J Neurol [PubMed]
2. Cervical longitudinally extensive myelitis after vaccination with inactivated virus-based COVID-19 vaccine (2022). Radiol Case Rep [PubMed]
3. Acute bilateral optic/chiasm neuritis with longitudinal extensive transverse myelitis in longstanding stable multiple sclerosis following vector-based vaccination against the SARS-CoV-2 (2022). J Neurol [PubMed]
4. Acute transverse myelitis after inactivated COVID-19 vaccine (2021). Ideggyogy Sz [PubMed]
5. Watch out for neuromyelitis optica spectrum disorder after inactivated virus vaccination for COVID-19 (2021). Neurol Sci [PubMed]
6. Acute Transverse Myelitis (ATM):Clinical Review of 43 Patients With COVID-19-Associated ATM and 3 Post-Vaccination ATM Serious Adverse Events With the ChAdOx1 nCoV-19 Vaccine (AZD1222) (2021). Front Immunol [PubMed]
7. Acute Transverse Myelitis Following COVID-19 Vaccination (2021). Vaccines (Basel) [PubMed]
8. A case of longitudinally extensive transverse myelitis following vaccination against Covid-19 (2021). J Neuroimmunol [PubMed]
9. Reporting of Acute Inflammatory Neuropathies with COVID-19 Vaccines: Subgroup Disproportionality Analyses in VigiBase (2021). Vaccines (Basel) [PubMed]
10. Acute Transverse Myelitis after COVID-19 Vaccination (2021). Medicina (Kaunas) [PubMed]
11. Lessons of the month 1: Longitudinal extensive transverse myelitis following AstraZeneca COVID-19 vaccination (2021). Clin Med (Lond) [PubMed]
12. Longitudinal extensive transverse myelitis following ChAdOx1 nCOV-19 vaccine: a case report (2021). BMC Neurol [PubMed]
13. Acute myelitis and ChAdOx1 nCoV-19 vaccine: Casual or causal association? (2021). J Neuroimmunol [PubMed]
14. SARS-CoV-2 Vaccination-Induced Transverse Myelitis (2021). Cureus [PubMed]
15. Neuromyelitis Optica in a Healthy Female After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA-1273 Vaccine (2021). Cureus [PubMed]

Encephalopathy

This is general brain dysfunction which can be complicated by seizures. People often seem confused and may have troubles with balance, headaches or vomiting.

1. COVID-19 mRNA vaccination leading to CNS inflammation: a case series (2022). J Neurol [PubMed]
2. A systematic review of cases of CNS demyelination following COVID-19 vaccination (2022). J Neuroimmunol [PubMed]
3. Neurological autoimmune diseases following vaccinations against SARS-CoV-2: a case series (2022). Eur J Neurol [PubMed]
4. A case of acute encephalopathy and non-ST segment elevation myocardial infarction following mRNA-1273 vaccination: possible adverse effect? (2021). Clin Exp Vaccine Res [PubMed]
5. Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination (2021). Clin Neurol Neurosurg [PubMed]
6. Postvaccinal Encephalitis after ChAdOx1 nCov-19 (2021). Ann Neurol [PubMed]
7. Post-COVID-19 vaccine acute hyperactive encephalopathy with dramatic response to methylprednisolone: A case report (2021). Ann Med Surg (Lond) [PubMed]

Multiple Sclerosis (MS)

A disease that effects the nerve cells in the brain and spinal cord. The underlying mechanism is the destruction by the immune system of the insulating covers of nervous system cells (which is called myelin). Since immune destruction can happen anywhere in the brain or body, people with MS have a wide range of symptoms including changes in sensation, weakness, balance, vision or speech. They can also experience thinking or emotional problems.

1. Acute relapse and poor immunization following COVID-19 vaccination in a rituximab-treated multiple sclerosis patient (2021). Hum Vaccin Immunother [PubMed]
2. Initial clinical manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine (2021). J Neuroimmunol [PubMed]
3. Severe Multiple Sclerosis Relapse After COVID-19 Vaccination: A Case Report (2021). Front Neurol [PubMed]
4. Humoral Response Induced by Prime-Boost Vaccination with the ChAdOx1 nCoV-19 and mRNA BNT162b2 Vaccines in a Teriflunomide-Treated Multiple Sclerosis Patient (2021). Vaccines (Basel) [PubMed]

Seizures

A seizure is a sudden, uncontrolled electrical disturbance in the brain. It can cause changes in behavior, movements, or feelings, and in levels of consciousness.

1. New-onset refractory status epilepticus following the ChAdOx1 nCoV-19 vaccine (2021). J Neuroimmunol [PubMed]

Depression

1. Depression following ChAdOx1-S/nCoV-19 vaccine (2021). Eur J Psychiatry [PubMed]

Other syndromes

1. Neurological side effects of SARS-CoV-2 vaccinations (2022). Acta Neurol Scand [PubMed]
2. Spectrum of neurological complications following COVID-19 vaccination (2022). Neurol Sci [PubMed]
3. Sudden sensorineural hearing loss after COVID-19 vaccination (2021). Int J Infect Dis [PubMed]
4. Unique Imaging Findings of Neurologic Phantosmia Following Pfizer-BioNtech COVID-19 Vaccination: A Case Report (2021). Top Magn Reson Imaging [PubMed]
5. Acute Hemichorea-Hemiballismus Following COVID-19 (AZD1222) Vaccination (2021). Mov Disord [PubMed]
6. Spectrum of Neuroimaging Findings in Post-COVID-19 Vaccination: A Case Series and Review of Literature (2021). Neurol Int [PubMed]
7. Neurological symptoms and neuroimaging alterations related with COVID-19 vaccine: Cause or coincidence? (2021). Clin Imaging [PubMed]
8. Hospital-based observational study of neurological disorders in patients recently vaccinated with COVID-19 mRNA vaccines (2021). J Neurol Sci [PubMed]
9. Headache Attributed to Vaccination Against COVID-19 (Coronavirus SARS-CoV-2) with the ChAdOx1 nCoV-19 (AZD1222) Vaccine: A Multicenter Observational Cohort Study (2021). Pain Ther [PubMed]
10. Amyotrophic neuralgia secondary to Vaxzevri (AstraZeneca) COVID-19 vaccine (2021). Neurologia (Engl Ed) [PubMed]
11. Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection (2021). Nat Med [PubMed]
12. Gastroparesis After Pfizer-BioNTech COVID-19 Vaccination (2021). Am J Gastroenterol [PubMed]
13. SARS-CoV-2 or SARS-CoV-2 vaccination associated Parsonage-Turner syndrome. Comment on: “Neuralgic amyotrophy and COVID-19 infection: 2 cases of spinal accessory nerve palsy” by Coll et al. Joint Bone Spine 2021;88:105196 (2021). Joint Bone Spine [PubMed]

Hepatitis

Hepatitis occurs when the body’s immune system attacks the liver.

1. Immune-mediated hepatitis with the Moderna vaccine, no longer a coincidence but confirmed (2022). J Hepatol [PubMed]
2. SARS-CoV-2 vaccination can elicit a CD8 T-cell dominant hepatitis (2022). J Hepatol [PubMed]
3. Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: A novel clinical entity? (2021). J Autoimmun [PubMed]
4. Auto-immune hepatitis following COVID vaccination (2021). J Autoimmun [PubMed]
5. Autoimmune hepatitis developing after the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine (2021). J Hepatol [PubMed]
6. Autoimmune hepatitis triggered by SARS-CoV-2 vaccination (2021). J Autoimmun [PubMed]
7. Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty? (2021). J Hepatol [PubMed]
8. Autoimmune- and complement-mediated hematologic condition recrudescence following SARS-CoV-2 vaccination (2021). Blood Adv [PubMed]
9. Hepatitis C Virus Reactivation Following COVID-19 Vaccination – A Case Report (2021). Int Med Case Rep J [PubMed]

Other auto-immune disease or reactivation of auto-immune disease

Auto-immune disease is when the body’s immune system mistakenly attacks part of the body. Some people experienced new auto-immune disease whereas others experienced a worsening of a known condition.

1. Hemophagocytic lymphohistiocytosis following ChAdOx1 nCov-19 vaccination (2022). J Med Virol [PubMed]
2. Postvaccination Multisystem Inflammatory Syndrome in Adult with No Evidence of Prior SARS-CoV-2 Infection (2022). Emerg Infect Dis [PubMed]
3. Induction and exacerbation of subacute cutaneous lupus erythematosus following mRNA-based or adenoviral vector-based SARS-CoV-2 vaccination (2022). Clin Exp Dermatol [PubMed]
4. Safety and tolerability of the COVID-19 messenger RNA vaccine in adolescents with juvenile idiopathic arthritis treated with tumor necrosis factor inhibitors (2022). Arthritis Rheumatol [PubMed]
5. Autoimmune encephalitis following ChAdOx1-S SARS-CoV-2 vaccination (2022). Neurol Sci [PubMed]
6. A flare of Still’s disease following COVID-19 vaccination in a 34-year-old patient (2022). Rheumatol Int [PubMed]
7. Reactive arthritis after COVID-19 vaccination (2021). Hum Vaccin Immunother [PubMed]
8. Comprehensive investigations revealed consistent pathophysiological alterations after vaccination with COVID-19 vaccines (2021). Cell Discov [PubMed]
9. Fatal Systemic Capillary Leak Syndrome after SARS-CoV-2Vaccination in Patient with Multiple Myeloma (2021). Emerg Infect Dis [PubMed]
10. Immune-Mediated Disease Flares or New-Onset Disease in 27 Subjects Following mRNA/DNA SARS-CoV-2 Vaccination (2021). Vaccines (Basel) [PubMed]
11. Polyarthralgia and Myalgia Syndrome after ChAdOx1 nCOV-19 Vaccination (2021). J Korean Med Sci [PubMed]
12. Lessons of the month 3: Haemophagocytic lymphohistiocytosis following COVID-19 vaccination (ChAdOx1 nCoV-19) (2021). Clin Med (Lond) [PubMed]
13. Vogt-Koyanagi-Harada Syndrome following COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccine (2021). Int J Retina Vitreous [PubMed]
14. Gross hematuria following vaccination for severe acute respiratory syndrome coronavirus 2 in 2 patients with IgA nephropathy (2021). Kidney Int [PubMed]
15. Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study (2021). Ann Rheum Dis [PubMed]
16. COVID-19 vaccines induce severe hemolysis in paroxysmal nocturnal hemoglobinuria (2021). Blood [PubMed]
17. Two Cases of Graves’ Disease Following SARS-CoV-2 Vaccination: An Autoimmune/Inflammatory Syndrome Induced by Adjuvants (2021). Thyroid [PubMed]
18. Three Cases of Subacute Thyroiditis Following SARS-CoV-2 Vaccine: Postvaccination ASIA Syndrome (2021). J Clin Endocrinol Metab [PubMed]
19. Thymic hyperplasia after mRNA based Covid-19 vaccination (2021). Radiol Case Rep [PubMed]
20. Autoantibody Release in Children after Corona Virus mRNA Vaccination: A Risk Factor of Multisystem Inflammatory Syndrome? (2021). Vaccines (Basel) [PubMed]
21. Reactivation of Vogt-Koyanagi-Harada disease under control for more than 6 years, following anti-SARS-CoV-2 vaccination (2021). J Ophthalmic Inflamm Infect [PubMed]
22. Recurrence of alopecia areata after covid-19 vaccination: A report of three cases in Italy (2021). J Cosmet Dermatol [PubMed]
23. Systemic capillary leak syndrome after ChAdOx1 nCOV-19 (Oxford-AstraZeneca) vaccination (2021). CMAJ [PubMed]
24. Increased Risk of Urticaria/Angioedema after BNT162b2 mRNA COVID-19 Vaccine in Health Care Workers Taking ACE Inhibitors (2021). Vaccines (Basel) [PubMed]
25. Effective DNA damage response after acute but not chronic immune challenge: SARS-CoV-2 vaccine versus Systemic Lupus Erythematosus (2021). Clin Immunol [PubMed]
26. Severe autoimmune hemolytic anemia following receipt of SARS-CoV-2 mRNA vaccine (2021). Transfusion [PubMed]

Anaphylaxis, allergic reactions, and asthma

Anaphylaxis is a severe, potentially life-threatening allergic reaction. With anaphylaxis and other allergies, including asthma, the body’s immune system reacts abnormally to a foreign substance.

1. IgE-mediated allergy to polyethylene glycol (PEG) as a cause of anaphylaxis to mRNA COVID-19 vaccines (2022). Clin Exp Allergy [PubMed]
2. Allergy to Polyethilenglicole of Anti-SARS CoV2 Vaccine Recipient: A Case Report of Young Adult Recipient and the Management of Future Exposure to SARS-CoV2 (2021). Vaccines (Basel) [PubMed]
3. Biphasic anaphylaxis after exposure to the first dose of Pfizer-BioNTech COVID-19 mRNA vaccine (2021). J Med Virol [PubMed]
4. Pfizer’s vaccine raises allergy concerns (2021). Science [PubMed]
5. Association of Self-reported High-Risk Allergy History With Allergy Symptoms After COVID-19 Vaccination (2021). JAMA Netw Open [PubMed]
6. Allergic reactions to COVID-19 vaccines: statement of the Belgian Society for Allergy and Clinical Immunology (BelSACI) (2021). Acta Clin Belg [PubMed]
7. Allergenic components of the mRNA-1273 vaccine for COVID-19: Possible involvement of polyethylene glycol and IgG-mediated complement activation (2021). Allergy [PubMed]
8. Allergic reactions to the first COVID-19 vaccine: A potential role of polyethylene glycol? (2021). Allergy [PubMed]
9. Anaphylaxis After the Covid-19 Vaccine in a Patient With Cholinergic Urticaria (2021). Mil Med [PubMed]
10. CoronaVac COVID-19 Vaccine-Induced Anaphylaxis: Clinical Characteristics and Revaccination Outcomes (2021). J Asthma Allergy [PubMed]
11. Anaphylaxis after Moderna COVID-19 vaccine (2021). Ther Adv Vaccines Immunother [PubMed]
12. Allergic Reactions After COVID-19 Vaccination-Putting Risk Into Perspective (2021). JAMA Netw Open [PubMed]
13. Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine – United States, December 14-23, 2020 (2021). MMWR Morb Mortal Wkly Rep [PubMed]
14. Biphasic anaphylaxis after first dose of messenger RNA coronavirus disease 2019 vaccine with positive polysorbate 80 skin testing result (2021). Ann Allergy Asthma Immunol [PubMed]
15. COVID-19 vaccines increase the risk of anaphylaxis (2021). Tidsskr Nor Laegeforen [PubMed]
16. COVID vaccination and asthma exacerbation: might there be a link? (2021). Int J Infect Dis [PubMed]
17. High anaphylaxis rates following vaccination with the Pfizer BNT162b2 mRNA vaccine against COVID-19 in Japanese healthcare workers: a secondary analysis of initial post-approval safety data (2021). J Travel Med [PubMed]
18. Acute Allergic Reactions to mRNA COVID-19 Vaccines (2021). JAMA [PubMed]
19. Practical handling of allergic reactions to COVID-19 vaccines: A position paper from German and Austrian Allergy Societies AeDA, DGAKI, GPA and ÖGAI (2021). Allergo J Int [PubMed]
20. Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine (2021). JAMA [PubMed]
21. Anaphylaxis associated with the mRNA COVID-19 vaccines: Approach to allergy investigation (2021). Clin Immunol [PubMed]
22. COVID-19 Vaccine Safety in Adolescents Aged 12-17 Years – United States, December 14, 2020-July 16, 2021 (2021). MMWR Morb Mortal Wkly Rep [PubMed]
23. Severe allergic reactions after COVID-19 vaccination with the Pfizer/BioNTech vaccine in Great Britain and USA: Position statement of the German Allergy Societies: Medical Association of German Allergologists (AeDA), German Society for Allergology and Clinical Immunology (DGAKI) and Society for Pediatric Allergology and Environmental Medicine (GPA) (2021). Allergo J Int [PubMed]
24. Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin diseases – practical recommendations. A position statement of ETFAD with external experts (2021). J Eur Acad Dermatol Venereol [PubMed]
25. An academic hospital experience screening mRNA COVID-19 vaccine risk using patient allergy history (2021). J Allergy Clin Immunol Pract [PubMed]
26. The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach (2021). J Allergy Clin Immunol Pract [PubMed]
27. Allergic reactions and adverse events associated with administration of mRNA-based vaccines. A health-care system experience (2021). Allergy Asthma Proc [PubMed]
28. Allergic Reactions and Anaphylaxis to LNP-Based COVID-19 Vaccines (2021). Mol Ther [PubMed]
29. Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US-December 14, 2020-January 18, 2021 (2021). JAMA [PubMed]
30. Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine – United States, December 14-23, 2020 (2021). Am J Transplant [PubMed]
31. Reports of anaphylaxis after coronavirus disease 2019 vaccination, South Korea, 26 February to 30 April 2021 (2021). Euro Surveill [PubMed]
32. Cumulative Adverse Event Reporting of Anaphylaxis After mRNA COVID-19 Vaccine (Pfizer-BioNTech) Injections in Japan: The First-Month Report (2021). Drug Saf [PubMed]
33. Relationship between pre-existing allergies and anaphylactic reactions post mRNA COVID-19 vaccine administration (2021). Vaccine [PubMed]
34. Prolonged Anaphylaxis to Pfizer Coronavirus Disease 2019 Vaccine: A Case Report and Mechanism of Action (2021). Crit Care Explor [PubMed]
35. Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Moderna COVID-19 Vaccine – United States, December 21, 2020-January 10, 2021 (2021). MMWR Morb Mortal Wkly Rep [PubMed]
36. Pseudo-Anaphylactic Reactions to Pfizer BNT162b2 Vaccine: Report of 3 Cases of Anaphylaxis Post Pfizer BNT162b2 Vaccination (2021). Vaccines (Basel) [PubMed]
37. Allergic reactions including anaphylaxis after receipt of the first dose of Moderna COVID-19 vaccine – United States, December 21, 2020-January 10, 2021 (2021). Am J Transplant [PubMed]
38. Polyethylene glycol (PEG) is a cause of anaphylaxis to the Pfizer/BioNTech mRNA COVID-19 vaccine (2021). Clin Exp Allergy [PubMed]
39. Immunization practices and risk of anaphylaxis: a current update, comprehensive of COVID-19 vaccination data (2021). Curr Opin Allergy Clin Immunol [PubMed]
40. Assessment of Allergic and Anaphylactic Reactions to mRNA COVID-19 Vaccines With Confirmatory Testing in a US Regional Health System (2021). JAMA Netw Open [PubMed]
41. Anaphylactic reactions to mRNA COVID-19 vaccines: A call for further study (2021). Vaccine [PubMed]
42. Sex differences in the incidence of anaphylaxis to LNP-mRNA COVID-19 vaccines (2021). Vaccine [PubMed]
43. COVID-19 vaccine-associated anaphylaxis: A statement of the World Allergy Organization Anaphylaxis Committee (2021). World Allergy Organ J [PubMed]

Lymphadenopathy and axillary adenopathy

This is a swelling of the lymph nodes of unclear significance.

1. COVID-19 Vaccine-Associated Subclinical Axillary Lymphadenopathy on Screening Mammogram (2022). Acad Radiol [PubMed]
2. Rare case of contralateral supraclavicular lymphadenopathy after COVID-19 vaccination: Computed tomography and ultrasonography findings (2021). Radiol Case Rep [PubMed]
3. COVID-19 mRNA Vaccination-Induced Lymphadenopathy Mimics Lymphoma Progression on FDG PET/CT (2021). Clin Nucl Med [PubMed]
4. COVID-19 Vaccination-Associated Lymphadenopathy on FDG PET/CT: Distinctive Features in Adenovirus-Vectored Vaccine (2021). Clin Nucl Med [PubMed]
5. COVID-19 vaccine induced Axillary and Pectoral Lymphadenopathy on PET scan (2021). Radiol Case Rep [PubMed]
6. COVID-19 Vaccination Induced Lymphadenopathy in a Specialized Breast Imaging Clinic in Israel: Analysis of 163 cases (2021). Acad Radiol [PubMed]
7. Evolution of Lymphadenopathy at PET/MRI after COVID-19 Vaccination (2021). Radiology [PubMed]
8. A Case of Cervical Lymphadenopathy After Vaccination Against COVID-19 (2021). Cureus [PubMed]
9. COVID-19 Vaccine-Related Axillary and Cervical Lymphadenopathy in Patients with Current or Prior Breast Cancer and Other Malignancies: Cross-Sectional Imaging Findings on MRI, CT, and PET-CT (2021). Korean J Radiol [PubMed]
10. Evolving Bilateral Hypermetabolic Axillary Lymphadenopathy on FDG PET/CT Following 2-Dose COVID-19 Vaccination (2021). Clin Nucl Med [PubMed]
11. COVID-19 post-vaccination lymphadenopathy: Report of cytological findings from fine needle aspiration biopsy (2021). Diagn Cytopathol [PubMed]
12. Lymphadenopathy in COVID-19 Vaccine Recipients: Diagnostic Dilemma in Oncologic Patients (2021). Radiology [PubMed]
13. Lymphadenopathy Following COVID-19 Vaccination: Imaging Findings Review (2021). Acad Radiol [PubMed]
14. Unilateral Lymphadenopathy After COVID-19 Vaccination: A Practical Management Plan for Radiologists Across Specialties (2021). J Am Coll Radiol [PubMed]
15. COVID-19 vaccine-related unilateral axillary lymphadenopathy: Pattern on screening breast MRI allowing for a benign assessment (2021). Clin Imaging [PubMed]
16. Unilateral axillary adenopathy induced by COVID-19 vaccine: US follow-up evaluation (2021). Eur Radiol [PubMed]
17. Acute onset supraclavicular lymphadenopathy coinciding with intramuscular mRNA vaccination against COVID-19 may be related to vaccine injection technique, Spain, January and February 2021 (2021). Euro Surveill [PubMed]
18. COVID-19 vaccine-related axillary lymphadenopathy in breast cancer patients: Case series with a review of literature (2021). Semin Oncol [PubMed]
19. Massive Cervical Lymphadenopathy Post-COVID-19 Vaccination (2021). Ear Nose Throat J [PubMed]
20. Regional lymphadenopathy following COVID-19 vaccination: Literature review and considerations for patient management in breast cancer care (2021). Eur J Cancer [PubMed]
21. Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine: incidence assessed by [18F]FDG PET-CT and relevance to study interpretation (2021). Eur J Nucl Med Mol Imaging [PubMed]
22. Unilateral axillary adenopathy in the setting of COVID-19 vaccine: Follow-up (2021). Clin Imaging [PubMed]
23. Axillary Adenopathy in Patients with Recent Covid-19 Vaccination: A New Diagnostic Dilemma (2021). Korean J Radiol [PubMed]
24. Lymphadenopathy Associated With the COVID-19 Vaccine (2021). Cureus [PubMed]
25. Supraclavicular lymphadenopathy following COVID-19 vaccination: an increasing presentation to the two-week wait neck lump clinic? (2021). Br J Oral Maxillofac Surg [PubMed]
26. COVID-19 Vaccination-Associated Axillary Adenopathy: Imaging Findings and Follow-Up Recommendations in 23 Women (2021). AJR Am J Roentgenol [PubMed]
27. Supraclavicular lymphadenopathy after COVID-19 vaccination in Korea: serial follow-up using ultrasonography (2021). Clin Imaging [PubMed]
28. Adenopathy Following COVID-19 Vaccination (2021). Radiology [PubMed]
29. Incidence of Axillary Adenopathy in Breast Imaging After COVID-19 Vaccination (2021). JAMA Oncol [PubMed]
30. COVID-19 vaccination and low cervical lymphadenopathy in the two week neck lump clinic – a follow up audit (2021). Br J Oral Maxillofac Surg [PubMed]
31. Cervical lymphadenopathy following coronavirus disease 2019 vaccine: clinical characteristics and implications for head and neck cancer services (2021). J Laryngol Otol [PubMed]
32. Coronavirus disease 2019 vaccine mimics lymph node metastases in patients undergoing skin cancer follow-up: A monocentre study (2021). Eur J Cancer [PubMed]
33. Oxford-AstraZeneca COVID-19 vaccination induced lymphadenopathy on [18F]Choline PET/CT-not only an FDG finding (2021). Eur J Nucl Med Mol Imaging [PubMed]

Cutaneous (skin) effects

Many different allergic, immune reactions, and infections can manifest on the skin as rashes.

1. Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: A registry-based study (2022). J Am Acad Dermatol [PubMed]
2. A case of toxic epidermal necrolysis after ChAdOx1 nCov-19 (AZD1222) vaccination (2022). Australas J Dermatol [PubMed]
3. Eosinophilic dermatosis after AstraZeneca COVID-19 vaccination (2022). J Eur Acad Dermatol Venereol [PubMed]
4. Vesiculobullous skin reactions induced by COVID-19 mRNA vaccine: report of four cases and review of the literature (2022). Clin Exp Dermatol [PubMed]
5. Generalized bullous fixed drug eruption after Oxford-AstraZeneca (ChAdOx1 nCoV-19) vaccination (2022). Clin Exp Dermatol [PubMed]
6. Cutaneous adverse reactions from 35,229 doses of Sinovac and AstraZeneca COVID-19 vaccination: a prospective cohort study in healthcare workers (2022). J Eur Acad Dermatol Venereol [PubMed]
7. Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases (2022). Br J Dermatol [PubMed]
8. Sweet syndrome after Oxford-AstraZeneca COVID-19 vaccine (AZD1222) in an elderly female (2021). Dermatol Ther [PubMed]
9. Rare cutaneous adverse effects of COVID-19 vaccines: a case series and review of the literature (2021). J Eur Acad Dermatol Venereol [PubMed]
10. Widespread purpura annularis telangiectodes following mRNA SARS-CoV-2 vaccine (2021). J Eur Acad Dermatol Venereol [PubMed]
11. Delayed cutaneous reactions after the administration of mRNA vaccines against COVID-19 (2021). J Allergy Clin Immunol Pract [PubMed]
12. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases (2021). J Am Acad Dermatol [PubMed]
13. Exacerbation of plaque psoriasis after inactivated and BNT162b2 mRNA COVID-19 vaccines: A report of two cases (2021). Dermatol Ther [PubMed]
14. Bullous drug eruption after second dose of mRNA-1273 (Moderna) COVID-19 vaccine: Case report (2021). J Infect Public Health [PubMed]
15. Onset/flare of psoriasis following the ChAdOx1 nCoV-19 Corona virus vaccine (Oxford-AstraZeneca/Covishield): Report of two cases (2021). Dermatol Ther [PubMed]
16. Exacerbation of Hailey-Hailey Disease Following SARS-CoV-2 Vaccination (2021). Acta Derm Venereol [PubMed]
17. Miller Fisher syndrome following BNT162b2 mRNA coronavirus 2019 vaccination (2021). BMC Neurol [PubMed]
18. Case Report: Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination (2021). Front Med (Lausanne) [PubMed]
19. Cutaneous adverse effects of the available COVID-19 vaccines (2021). Clin Dermatol [PubMed]
20. A case series of cutaneous COVID-19 vaccine reactions at Loma Linda University Department of Dermatology (2021). JAAD Case Rep [PubMed]

Eye disorders

Immune disorders and problems with blood vessels, blood clotting (and bleeding) can manifest as eye problems.

1. Bilateral uveitis after inoculation with COVID-19 vaccine: A case report (2021). Int J Infect Dis [PubMed]
2. Bilateral Acute Macular Neuroretinopathy After Vaccination Against SARS-CoV-2 (2021). JAMA Ophthalmol [PubMed]
3. Ocular Adverse Events After COVID-19 Vaccination (2021). Ocul Immunol Inflamm [PubMed]
4. Acute-onset central serous retinopathy after immunization with COVID-19 mRNA vaccine (2021). Am J Ophthalmol Case Rep [PubMed]
5. Bilateral Immune-Mediated Keratolysis After Immunization With SARS-CoV-2 Recombinant Viral Vector Vaccine (2021). Cornea [PubMed]
6. Central retinal vein occlusion after mRNA SARS-CoV-2 vaccination: A case report (2021). Indian J Ophthalmol [PubMed]
7. Tolosa-Hunt Syndrome Presenting After COVID-19 Vaccination (2021). Cureus [PubMed]

Rhabdomyolysis

This is syndrome due to direct or indirect muscle injury. It results from death of muscle cells and the release of their contents into the blood stream. This can lead to serious complications such as renal (kidney) failure. In rare cases, rhabdomyolysis can even cause death.

1. COVID-19 mRNA vaccine induced rhabdomyolysis and fasciitis (2022). J Neurol [PubMed]
2. Case Report: ANCA-Associated Vasculitis Presenting With Rhabdomyolysis and Pauci-Immune Crescentic Glomerulonephritis After Pfizer-BioNTech COVID-19 mRNA Vaccination (2021). Front Immunol [PubMed]
3. COVID-19 vaccine induced rhabdomyolysis: Case report with literature review (2021). Diabetes Metab Syndr [PubMed]

Kidney injury

Kidney injury can be from an immune attack or from chemicals (drugs) that injure kidney cells.

1. Haematuria, a widespread petechial rash, and headaches following the Oxford AstraZeneca ChAdOx1 nCoV-19 Vaccination (2021). BMJ Case Rep [PubMed]
2. Nephrotic Syndrome Following ChAdOx1 nCoV-19 Vaccine Against SARScoV-2 (2021). Kidney Int Rep [PubMed]
3. A case of gross hematuria and IgA nephropathy flare-up following SARS-CoV-2 vaccination (2021). Kidney Int [PubMed]
4. Minimal change disease and acute kidney injury following the Pfizer-BioNTech COVID-19 vaccine (2021). Kidney Int [PubMed]
5. New-onset Nephrotic Syndrome after Janssen COVID-19 Vaccination: a Case Report and Literature Review (2021). J Korean Med Sci [PubMed]
6. Acute kidney injury with gross hematuria and IgA nephropathy after COVID-19 vaccination (2021). Kidney Int [PubMed]
7. Minimal Change Disease With Severe Acute Kidney Injury Following the Oxford-AstraZeneca COVID-19 Vaccine: A Case Report (2021). Am J Kidney Dis [PubMed]
8. ANCA glomerulonephritis after the Moderna COVID-19 vaccination (2021). Kidney Int [PubMed]

Myofunctional

These are disorders of muscles that result in weakness or reduced function.

1. Transient Oculomotor Palsy Following the Administration of the Messenger RNA-1273 Vaccine for SARS-CoV-2 Diplopia Following the COVID-19 Vaccine (2021). J Neuroophthalmol [PubMed]
2. Inflammatory myositis after ChAdOx1 vaccination (2021). Lancet Rheumatol [PubMed]
3. Reported orofacial adverse effects of COVID-19 vaccines: The knowns and the unknowns (2021). J Oral Pathol Med [PubMed]
4. Nervous and Muscular Adverse Events after COVID-19 Vaccination: A Systematic Review and Meta-Analysis of Clinical Trials (2021). Vaccines (Basel) [PubMed]

Infections

1. Varicella-zoster and herpes simplex virus reactivation post-COVID-19 vaccination: a review of 40 cases in an International Dermatology Registry (2022). J Eur Acad Dermatol Venereol [PubMed]
2. Acute Retinal Necrosis from Reactivation of Varicella Zoster Virus following BNT162b2 mRNA COVID-19 Vaccination (2021). Ocul Immunol Inflamm [PubMed]
3. Herpes-like skin lesion after AstraZeneca vaccination for COVID-19: A case report (2021). Clin Case Rep [PubMed]
4. Recurrent herpes zoster after COVID-19 vaccination in patients with chronic urticaria being treated with cyclosporine-A report of 3 cases (2021). J Cosmet Dermatol [PubMed]

Other rare disorders

1. Vaccine-induced interstitial lung disease: a rare reaction to COVID-19 vaccination (2022). Thorax [PubMed]
2. Pancreas allograft rejection occurring after ChAdOx1 nCoV-19 vaccine (2021). Diabetes Metab [PubMed]
3. [Lipschütz Ulcers After the AstraZeneca COVID-19 Vaccine] (2021). Actas Dermosifiliogr (Engl Ed) [PubMed]
4. Acute Eosinophilic Pneumonia Associated With the Anti-COVID-19 Vaccine AZD1222 (2021). Cureus [PubMed]
5. Rituximab-induced acute lympholysis and pancytopenia after COVID-19 vaccination (2021). Clin Case Rep [PubMed]

Population studies

1. Prevalence of severe adverse events among health professionals after receiving the first dose of the ChAdOx1 nCoV-19 coronavirus vaccine (Covishield) in Togo, March 2021 (2021). Arch Public Health [PubMed]

Cancer progression

1. Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster Shot: A Case Report (2021). Front Med (Lausanne) [PubMed]
2. Lung squamous cell carcinoma with hemoptysis after vaccination with tozinameran (BNT162b2, Pfizer-BioNTech) (2021). Thorac Cancer [PubMed]

Death

1. Autopsy Findings and Causality Relationship between Death and COVID-19 Vaccination: A Systematic Review (2021). J Clin Med [PubMed]
2. An Insight into the Role of Postmortem Immunohistochemistry in the Comprehension of the Inflammatory Pathophysiology of COVID-19 Disease and Vaccine-Related Thrombotic Adverse Events: A Narrative Review (2021). Int J Mol Sci [PubMed]
3. COVID-19 Vaccine and Death: Causality Algorithm According to the WHO Eligibility Diagnosis (2021). Diagnostics (Basel) [PubMed]